communication
Integrated care for older people Guidelines on community-level interventions to manage declines in intrinsic capacity
Integrated care for older people Guidelines on community-level interventions to manage declines in intrinsic capacity
Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity
ISBN 978-92-4-155010-9
© World Health Organization 2017
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO
licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization.
Suggested citation. Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.
Cover: The painting is “Wet in Wet” by Gusta van der Meer. At 75 years of age, Gusta has an artistic style that is fresh, distinctive and vibrant. A long-time lover of art, she finds that dementia is no barrier to her artistic expression. Appreciated not just for her art but also for the support and encouragement she gives to other artists with dementia, Gusta participates in a weekly art class. Copyright by Gusta van der Meer. All rights reserved.
Printed in Switzerland
iii Contents
Contents
Acknowledgements .......................................................................................................................... iv
Abbreviations .................................................................................................................................... v
Executive summary ......................................................................................................................... vii
1 Introduction ............................................................................................................................ 1
1.1 Rationale for these guidelines ..................................................................................................... 2
1.2 Scope ......................................................................................................................................... 2
1.3 Target audience ......................................................................................................................... 3
1.4 Guiding principles ...................................................................................................................... 3
2 Guideline development process ............................................................................................ 5
2.1 Guideline development group .................................................................................................... 5
2.2 Declarations of interest and management of conflict .................................................................. 5
2.3 Identifying, appraising and synthesizing available evidence ......................................................... 5
2.4 Consensus decision-making during the guideline development group meeting ........................... 6
2.5 Document preparation and peer review ..................................................................................... 6
3 Evidence and recommendations ........................................................................................... 7
3.1 Module I: Declining physical and mental capacities ..................................................................... 8
3.2 Module II: Geriatric syndromes ..................................................................................................17
3.3 Module III: Caregiver support ....................................................................................................21
4 Implementation considerations ........................................................................................... 25
5 Publication, dissemination and evaluation ........................................................................ 29
5.1 Publication and dissemination ...................................................................................................29
5.2 Monitoring and evaluation ........................................................................................................29
5.3 Future review and update......................................................................................................... 30
References .........................................................................................................................................31
Annex 1: Guideline development group (GDG) members ........................................................... 34
Annex 2: Assessment of conflicts of interest ................................................................................ 35
Annex 3: Scoping questions ........................................................................................................... 38
Annex 4: Evidence process ..............................................................................................................41
Glossary ............................................................................................................................................ 44
iv Integrated care for older people
Acknowledgements
These ICOPE guidelines were coordinated by the World Health Organization (WHO) Department of Ageing and Life Course. Islene Araujo de Carvalho, Jotheeswaran Amuthavalli Thiyagarajan, Yuka Sumi and John Beard oversaw the preparation of this document, with thanks to Susanna Volk for administrative support.
WHO acknowledges the technical contributions of the guideline development group (GDG). In alphabetical order: Emiliano Albanese (WHO Collaborating Centre, University of Geneva, Geneva, Switzerland); Olivier Bruyère (University of Liège, Liège, Belgium); Matteo Cesari (Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France); Alan Dangour (London School of Hygiene & Tropical Medicine, London, United Kingdom of Great Britain and Northern Ireland); Amit Dias (Goa Medical College, Goa, India); Astrid Fletcher (London School of Hygiene & Tropical Medicine, London, United Kingdom); Dorothy Forbes (University of Alberta, Edmonton, Canada); Anne Forster (University of Leeds, Leeds, United Kingdom); Mariella Guerra (Institute of Memory, Depression and Related Disorders, Lima, Peru); Jill Keeffe (WHO Collaborating Centre for Prevention of Blindness, Hyderabad, India); Ngaire Kerse (University of Auckland, Auckland, New Zealand); Qurat ul Ain Khan (Aga Khan University Hospital, Karachi, Pakistan); Chiung- ju Liu (Indiana University, Indianapolis, Indiana, United States of America); Gudlavalleti V.S. Murthy (Indian Institute of Public Health, Hyderabad, Madhapur, India); Serah Nyambura Ndegwa (University of Nairobi, Nairobi, Kenya); Joseph G. Ouslander (Florida Atlantic University, Boca Raton, United States); Jean-Yves Reginster (University of Liège, Liège, Belgium); Luis Miguel F. Gutiérrez Robledo (Institutos Nacionales de Salud de México, Mexico City, Mexico); John F. Schnelle (Vanderbilt University Medical Center, Nashville, United States); Kelly Tremblay (University of Washington, Seattle, United States); Jean Woo (The Chinese University of Hong Kong, Hong Kong, China). Special thanks go to the chair of the GDG, Martin Prince (King’s College London, London, United Kingdom).
The WHO Department of Ageing and Life Course would like to express its appreciation to the external review group: A.B. Dey (All India Institute of Medical Science, New Delhi, India); Minha Rajput-Ray (Global Centre for Nutrition and Health, Cambridge, United Kingdom); Sumantra Ray (Medical Research Council, Cambridge, United Kingdom); Richard Uwakwe (Nnamdi Azikiwe University, Awka, Nigeria).
The department would like to thank the ICOPE guidelines steering group: Said Arnaout (WHO Regional Office for the Eastern Mediterranean); Anjana Bhushan (WHO Regional Office for the Western Pacific); Alessandro Rhyl
Demaio (WHO Department of Nutrition for Health and Development); Shelly Chadha (WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention); Tarun Dua (WHO Department of Mental Health and Substance Abuse); Manfred Huber (WHO Regional Office for Europe); Silvio Paolo Mariotti (WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention); Maria Alarcos Moreno Cieza (WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention); Alana Margaret Officer (WHO Department of Ageing and Life Course); Juan Pablo Peña-Rosas (WHO Department of Nutrition for Health and Development); Anne Margriet Pot (WHO Department of Ageing and Life Course); Ritu Sadana (WHO Department of Ageing and Life Course); Céline Yvette Seignon Kandissounon (WHO Regional Office for Africa); Maria Pura Solon (WHO Department of Nutrition for Health and Development); Mark Humphrey Van Ommeren (WHO Department of Mental Health and Substance Abuse); Enrique Vega Garcia (WHO Regional Office for the Americas); Temo Waqanivalu (WHO Prevention of Noncommunicable Diseases Management Team).
The WHO Department of Ageing and Life Course is grateful to the members of the WHO systematic review team: Alessandra Stella (Independent Consultant, Rome, Italy); Kralj Carolina (King’s College London, London, United Kingdom); Meredith Fendt-Newlin (King’s College London, London, United Kingdom).
King’s College London, London, United Kingdom, supported the development of the ICOPE guidelines by providing staff to work on the systematic reviews and assisting in the management of the GDG. King’s College London did not receive any external funding for engaging with WHO on the development of these guidelines. Finally, the peer-reviewers are due thanks for their thoughtful feedback of a preliminary version of these guidelines.
The WHO Department of Ageing and Life Course acknowledges the financial support of the Government of Japan for the development of the ICOPE guidelines.
Donors do not fund specific guidelines and do not participate in any decision related to the guideline development process, including for the composition of research questions, the memberships of the guideline groups, the conduct and interpretation of systematic reviews, or the formulation of the recommendations.
Editing, design and layout were provided by Green Ink, United Kingdom (greenink.co.uk).
v Abbreviations
Abbreviations
ADLs activities of daily living
AGREE Appraisal of Guidelines for Research and Evaluation
GDG guideline development group
GRADE Grading of Recommendations Assessment, Development and Evaluation
ICOPE integrated care for older people
mhGAP Mental Health Gap Action Programme
PFMT pelvic floor muscle training
PICO population, intervention, comparison, outcome
RCT randomized controlled trial
WHO World Health Organization
vii Executive summary
Over the past 50 years, socioeconomic development in
most regions has been accompanied by large reductions
in fertility and equally dramatic increases in life
expectancy. This phenomenon has led to rapid changes
in the demographics of populations around the world:
the proportion of older people in general populations
has increased substantially within a relatively short
period of time.
Numerous underlying physiological changes occur with
increasing age, and for older people the risks of
developing chronic disease and care dependency
increase. By the age of 60 years, the major burden of
disability and death arises from age-related losses in
hearing, seeing and moving, and conditions such as
dementia, heart disease, stroke, chronic respiratory
disorder, diabetes and musculoskeletal conditions such
as osteoarthritis and back pain.
The 2015 World Health Organization (WHO) World
report on ageing and health defines the goal of Healthy
Ageing as helping people in “developing and
maintaining the functional ability that enables well-
being”. Functional ability is defined in the report as the
“health-related attributes that enable people to be and
to do what they have reason to value”. Intrinsic capacity,
finally, is “the composite of all of the physical and
mental capacities that an individual can draw on”. The
WHO public health framework for Healthy Ageing
focuses on the goal of maintaining intrinsic capacity and
functional ability across the life course.
Health care professionals in clinical settings can detect
declines in physical and mental capacities (clinically
expressed as impairments) and deliver effective
interventions to prevent and delay progression. Yet early
markers of declines in intrinsic capacity, such as
decreased gait speed or muscle strength, are often not
identified, treated or monitored, which are crucial
actions if these declines are to be reversed or delayed.
The majority of health care professionals lack guidance
or training to recognize and manage impairments in
older age. There is a pressing need to develop
comprehensive community-based approaches and to
introduce interventions at the primary health care level
to prevent declines in capacity. These guidelines address
this need.
The recommendations provided here on integrated care
for older people (ICOPE) offer evidence-based guidance
to health care providers on the appropriate approaches
at the community level to detect and manage important
declines in physical and mental capacities, and to deliver
interventions in support of caregivers. These standards
can act as the basis for national guidelines and for the
inclusion of older people’s health care in primary care
programmes, using a person-centred and integrated
approach.
Supplementary to the present guidance is an ICOPE
implementation guide, which addresses how to set
person-centred care goals, develop an integrated care
plan, and provide self-management support. This will
also include guidance to lead the practitioner through
the process of assessing, classifying and managing
declining physical and mental capacities in older age in
an integrated way.
The present guidelines and the supplementary
implementation guide are both organized into three
modules.
• Module I: Declines in intrinsic capacity, including mobility loss, malnutrition, visual impairment and
hearing loss, cognitive impairment, and depressive
symptoms
• Module II: Geriatric syndromes associated with care dependency, including urinary incontinence and
risk of falls
• Module III: Caregiver support: interventions to support caregiving and prevent caregiver strain.
The physical and mental impairments were selected
because they represent, consistent with the WHO
Executive summary
viii Integrated care for older people
framework on Healthy Ageing, clinically important
declines in physical and mental capacities, and are
strong predictors of mortality and care dependency in
older age. The recommendations need to be
implemented using an older person-centred and
integrated approach. The rationale and evidence base
for doing this has been described previously in the
WHO World report on ageing and health.
The ICOPE implementation guide will outline the
important elements that should be taken into account
at the clinical level when designing integrated care for
older people, and the steps required to deliver the
present community-level recommendations in an
integrated manner.
These ICOPE guidelines and associated products are
key tools in support of the implementation of the
WHO Global strategy and action plan on ageing and
health approved by the World Health Assembly in
2016. WHO will partner with ministries of health,
nongovernmental organizations, professional
associations and academic institutions to disseminate
these guidelines, and support their adaptation and
implementation by Member States.
Guideline development methods The process followed in the development of these
guidelines is outlined in the WHO handbook for
guideline development and has involved:
(i) establishment of the steering group, guideline
development group (GDG), external review group and
systematic review team; (ii) declarations of interest by
GDG members and peer reviewers; (iii) identification,
appraisal and synthesis of available evidence;
(iv) formulation of the recommendations with inputs
from a wide range of stakeholders; and (v) preparation
of documents and plans for dissemination.
The GDG is an international group of experts (Annex 1)
representing the six WHO regions. The scope of the
guidelines and questions (Annex 3) were defined in
consensus with the GDG members. A total of nine
PICO (population, intervention, comparison group,
outcomes) questions were formulated by the GDG and
the steering group with inputs from external reviewers.
A series of searches for systematic reviews and
randomized controlled trials was conducted across the
Cochrane Library, Embase, Ovid MEDLINE and
PsycINFO databases applying a search strategy
involving the United States Library of Medicine’s MeSH
terms where appropriate (Annex 4). For each
preselected critical question, evidence profiles
following the Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
approach were prepared from existing systematic
reviews or systematic reviews updated with newer
trials.
The recommendations were formulated by the GDG
during a meeting at WHO headquarters in Geneva,
Switzerland, 24–26 November 2015. The GRADE
methodology continued to be followed, to prepare
evidence profiles related to preselected topics, based
on up-to-date systematic reviews. The GDG members
discussed the evidence, clarified points and interpreted
the findings to develop recommendations. The GDG
considered the relevance of the recommendations for
older people, considering the balance of benefit and
harm for each intervention, the values and preferences
of older people, and the costs and resource use as well
as other relevant practical issues of concern for
providers in low- and middle-income countries.
The recommendations now formed in these
guidelines are interrelated, and aim to produce
synergistic effects on the intrinsic capacities and
functional abilities of individuals. Although
recommendations were made on the separate
interventions, it was recognized that these would be
best implemented in the context of a comprehensive
needs assessment and an integrated care plan.
The key recommendations for the secondary
prevention of declines in physical and mental
capacities are classified by the strength of
recommendation. When making a strong
recommendation, the GDG was confident that any
desirable effects outweighed any undesirable effects.
For conditional recommendations, the GDG concluded
that the desirable effects of adherence probably
outweighed any harm. The GDG members reached a
unanimous agreement on the majority of the
recommendations and ratings. Voting was required on
the recommendations about cognitive training and
respite care and the GDG decided that, because the
evidence was unavailable, the group would not
formulate any recommendations on these two
interventions.
ix Executive summary
Recommendations Module I: Declining physical and mental capacities
Mobility loss Recommendation 1: Multimodal exercise, including progressive strength resistance training and other exercise components (balance, flexibility and aerobic training), should be recommended for older people with declining physical capacity, measured by gait speed, grip strength and other physical performance measures. (Quality of the evidence: moderate; Strength of the recommendation: strong)
Malnutrition Recommendation 2: Oral supplemental nutrition with dietary advice should be recommended for older people affected by undernutrition. (Quality of the evidence: moderate; Strength of the recommendation: strong)
Visual impairment
Recommendation 3: Older people should receive routine screening for visual impairment in the primary care setting, and timely provision of comprehensive eye care. (Quality of the evidence: low; Strength of the recommendation: strong)
Hearing loss Recommendation 4: Screening followed by provision of hearing aids should be offered to older people for timely identification and management of hearing loss. (Quality of the evidence: low; Strength of the recommendation: strong)
Cognitive impairment
Recommendation 5: Cognitive stimulation can be offered to older people with cognitive impairment, with or without a formal diagnosis of dementia. (Quality of the evidence: low; Strength of the recommendation: conditional)
Depressive symptoms
Recommendation 6: Older adults who are experiencing depressive symptoms can be offered brief, structured psychological interventions, in accordance with WHO mhGAP intervention guidelines, delivered by health care professionals with a good understanding of mental health care for older adults. (Quality of the evidence: very low; Strength of the recommendation: conditional)
Module II: Geriatric syndromes
Urinary incontinence
Recommendation 7: Prompted voiding for the management of urinary incontinence can be offered for older people with cognitive impairment. (Quality of the evidence: very low; Strength of the recommendation: conditional)
Recommendation 8: Pelvic floor muscle training (PFMT), alone or combined with bladder control strategies and self-monitoring, should be recommended for older women with urinary incontinence (urge, stress or mixed). (Quality of the evidence: moderate; Strength of the recommendation: strong)
Risk of falls Recommendation 9: Medication review and withdrawal (of unnecessary or harmful medication) can be recommended for older people at risk of falls. (Quality of the evidence: low; Strength of the recommendation: conditional)
Recommendation 10: Multimodal exercise (balance, strength, flexibility and functional training) should be recommended for older people at risk of falls. (Quality of the evidence: moderate; Strength of the recommendation: strong)
Recommendation 11: Following a specialist’s assessment, home modifications to remove environmental hazards that could cause falls should be recommended for older people at risk of falls. (Quality of the evidence: moderate; Strength of the recommendation: strong)
Recommendation 12: Multifactorial interventions integrating assessment with individually tailored interventions can be recommended to reduce the risk and incidence of falls among older people. (Quality of the evidence: low; Strength of the recommendation: conditional)
Module III: Caregiver support
Recommendation 13: Psychological intervention, training and support should be offered to family members and other informal caregivers of care-dependent older people, particularly but not exclusively when the need for care is complex and extensive and/or there is significant caregiver strain. (Quality of the evidence: moderate; Strength of the recommendation: strong)
1 Introduction
In most regions over the past 50 years, socioeconomic
development has been accompanied by large drops in
fertility and equally dramatic rises in life expectancy. This
phenomenon has led to rapidly ageing populations
around the world. The fastest rate of change is occurring
in low- and middle-income countries. Even in sub-
Saharan Africa, which has the world’s youngest
population structure, the number of people over 60
years of age is expected to increase over threefold, from
46 million in 2015 to 147 million in 2050 (1).
With increasing age, numerous underlying physiological
changes occur, and the risks for older people developing
chronic disease and care dependency increase. The major
population burdens of disability and death in people over
60 arise from age-related losses in hearing, seeing and
moving, and conditions such as dementia, heart disease,
stroke, chronic respiratory disorder, diabetes and
osteoarthritis. These are not problems just for higher-
income countries; in fact, the burden associated with
these conditions affecting older people is generally far
higher in low- and middle-income countries (2).
Population ageing will dramatically increase the
proportion and number of people needing long-term
care in countries at all levels of development. This will
occur at the same time as the proportion of younger
people who might be available to provide care will fall,
and the societal role of women, who have until now
been the main care providers, is changing. Therefore, an
approach to prevent and reverse functional decline and
care dependency in older age is critical to improving
public health responses to population ageing. Such an
approach is needed urgently.
The 2015 World Health Organization (WHO) World
report on ageing and health defines the goal of Healthy
Ageing as helping people to develop and maintain the
functional ability that enables well-being (1). Functional
ability is defined in the report as the “health-related
attributes that enable people to be and to do what they
have reason to value”. Intrinsic capacity is “the
composite of all of the physical and mental capacities
that an individual can draw on”. A summary of these
definitions is given in the box below.
The WHO public health framework for Healthy Ageing
focuses on the goal of maintaining function across the
life course (Fig. 1). Intervening at an early stage is
essential because the process of becoming frail or care
dependent can be delayed, slowed or even partly
reversed by interventions targeted early in the process of
functional decline (3–5). Health care professionals in
clinical settings can detect declining physical and mental
capacities (clinically expressed as impairments) and
deliver effective interventions to prevent and slow or
halt the progression of these impairments.
In 2016, following the release of the WHO World report
on ageing and health (1), the Global strategy and action
plan on ageing and health was adopted by the World
Health Assembly (6). Both reflect a new conceptual
model for Healthy Ageing that is built around the
concept of the intrinsic capacities and functional abilities
of older people, rather than the absence of disease. The
rationale and evidence base for providing older person-
centred and integrated care have been described in the
World report on ageing and health and a publication in
The Lancet (7). The present community-level ICOPE
Intrinsic capacity and functional ability
WHO defines intrinsic capacity (IC) as the combination of the individual’s physical and mental, including psychological, capacities; and functional ability (FA) as the combination and interaction of IC with the environment a person inhabits.
Introduction1
2 Integrated care for older people
Fig. 1: A public health framework for Healthy Ageing: opportunities for public-health action across the life course
Intrinsic capacity and functional ability do not remain constant but decline with age as a result of underlying diseases
and the ageing process.
guidelines were rewritten to align with this new WHO
concept of Healthy Ageing. The implementation guide to
accompany them aims to provide further evidence-based
guidance to health care providers on appropriate
approaches to detect and manage important reductions
in physical and mental capacities, and to deliver
interventions to support caregivers.
1.1 Rationale for these guidelines Declining intrinsic capacity is very frequently
characterized by common problems in older age such as
difficulties with hearing, seeing, remembering, moving,
or performing daily or social activities. Yet these
problems are often overlooked by health care
professionals. Early markers of decline in intrinsic
capacity, such as decreased gait speed or reduced
muscle strength, are often not identified, treated or
monitored, which is crucial to do if they are to be
reversed or delayed. The majority of health care
professionals lack guidance or training to recognize and
manage impairments in older age.
Based on the belief that there is no treatment available
for their problems, older people may disengage from
services, not adhere to treatment and/or not attend
primary health care clinics. There is a pressing need to
develop comprehensive community-based approaches
and to introduce interventions to prevent declining
capacity and provide support to informal caregivers.
These guidelines address this need.
Approaching older people through the lens of
intrinsic capacity and the environment in which they live
helps to ensure that health services are orientated
towards the outcomes that are most relevant to their
daily lives. This approach can also help to avoid
unnecessary treatments, polypharmacy and side-
effects (1).
1.2 Scope These guidelines cover evidence-based interventions to
manage common declines in capacity in older age,
covering mobility, nutrition or vitality, vision, hearing,
cognition and mood, as well as the important geriatric
syndromes of urinary incontinence and risk of falls.
These conditions were selected because they express
reductions in physical and mental capacities, as outlined
in the WHO framework on Healthy Ageing (7), and are
strong independent predictors of mortality and care
dependency in older age (8).
Declining physical and/or mental capacity can be
identified by the presence of one or more of the
following indicators:
High and stable capacity Declining capacity Significant loss of capacity
Functional ability
Intrinsic capacity
3 Introduction
Mobility loss: After reaching a peak in early
adulthood, muscle mass tends to decline with
increasing age, and this can be associated with
declining strength and musculoskeletal function (9).
One way of measuring muscle function is to measure
hand grip strength, which is a strong predictor of
mortality (10, 11).
Malnutrition: Malnutrition represents a major
problem that affects 22% of older adults (12). It often
manifests as reduced muscle and bone mass, and it
increases the risk of frailty. Malnutrition has also been
associated with diminished cognitive function,
diminished ability to care for oneself, and a higher risk
of becoming care dependent.
Visual impairment and hearing loss: Ageing is
frequently associated with decrements in both vision
and hearing. Worldwide, more than 180 million people
over 65 years of age have hearing loss that interferes
with understanding normal conversational speech.
Severe visual impairment is highly prevalent in people
over 70 years of age, and a leading cause of blindness
in high-income and upper-middle-income
countries (13, 14).
Cognitive impairment: Worldwide, 46.8 million older
people are living with dementia. This number is
expected to double every 20 years, reaching
74.7 million in 2030 (15). Many cognitive functions
begin to decline at a relatively young age, with
different functions decreasing at different rates. In mild
cognitive impairment, the cognitive deficit is less severe
than in dementia, and normal daily function and
independence are generally maintained. This chronic
condition is a precursor to dementia in up to a third of
cases (16).
Depressive symptoms: Episodes of affective disorders
might be expected to be more prevalent in older age
due to the increased risk of adverse life events.
Compared with younger adults, older people more
often have substantial depressive symptomatology
without meeting the diagnostic criteria for a depressive
disorder. This condition is often referred to as
subthreshold depression, and affects nearly 1 in 10
older adults (17). Subthreshold depression also has a
major impact on the quality of life of older people, and
is a major risk factor for a depressive disorder (18).
The relationship of these indicators to care dependency,
disability and other important adverse health outcomes
has been proposed in numerous different conceptual
definitions, and longitudinal studies have shown strong
predictive validity for these indicators in relation to the
onset of care dependency and mortality (8). A clear
understanding of the nature of declining physical and
mental capacities, and of the relationships to ageing and
chronic diseases, is paramount to informing and
prioritizing interventions and strategies.
1.3 Target audience Health care providers working in communities and in
primary and secondary health care settings are the
primary audience for these ICOPE guidelines on
community-level interventions. Equally, these guidelines
are also aimed at professionals responsible for
developing training curricula in medicine, nursing and
public health.
Other targeted audiences for this document include
health care managers – such as programme managers
organizing health care services at national, regional and
district levels – entities funding and implementing public
health programmes, and nongovernmental organizations
and charities active in the care of older people in the
community setting.
1.4 Guiding principles The following principles have informed the development
of these guidelines and should guide the implementation
of the recommendations.
• The guidelines contribute to the achievement of key global goals in the WHO Global strategy and plan of
action on ageing and health (6, 19), which outlines
the role of health systems in promoting Healthy
Ageing by optimizing the trajectories of intrinsic
capacity.
• These guidelines are also a tool for the implementation of the WHO framework on
integrated people-centred health services (20). This
framework calls for shifting the way health services
are managed and delivered, and proposes key
approaches to be adopted to ensure quality
integrated care for people, including older people: a
strong case-management system in which individual
needs are assessed; the development of a
comprehensive care plan; and services driven towards
the goal of maintaining intrinsic capacity and
functional ability.
4 Integrated care for older people
• In addition to promoting integrated person-centred care, the recommendations should be implemented
with a view to supporting ageing in place; health
services should therefore provide care where people
live. The interventions are designed to be
implemented through models of care that prioritize
primary care and community-based care. This
includes a focus on home-based interventions,
community engagement and a fully integrated
referral system.
These guidelines provide evidence-informed
interventions that non-specialized health workers can
implement in primary health care and community
settings. One of the key principles to underpin the
development of these guidelines is the recognition of
the critical role that community health workers play in
increasing access to quality essential health services, in
the context of national primary health care and universal
health coverage. WHO guidance is available for country
programme managers and global partners, placing
emphasis on those key elements that strengthen the
capacity of community health workers. This covers, for
example, health system and programme considerations,
and the roles and core competencies of community
health workers (21).
5 Guideline development process
The WHO handbook for guideline development (22)
outlines the process used in the development of these
guidelines, following the steps below.
2.1 Guideline development group A WHO guideline steering group, led by the Department
of Ageing and Life Course, was established with
representatives from relevant WHO departments and
programmes with an interest in the provision of scientific
advice regarding older people. The guideline steering
group provided overall supervision of the guideline
development process. Two additional groups were
formed: a guideline development group (GDG) and an
external review group.
The GDG included a panel of academics and clinicians
with multidisciplinary expertise on the conditions
covered by the guidelines, plus geriatricians/specialist
doctors in the care of older people. Consideration was
given to the balance of gender and of geographically
diverse representation (see Annex 1).
Potential members of the GDG were selected on the
basis of their contribution to the area, as well as on the
need for regional and area-of-expertise diversity. As a
respected researcher in the field, the chair was selected
for his extensive experience of guideline development
methodology, and his participation in other guideline
development groups. Each potential GDG member was
asked to complete the WHO declaration-of-interest
form. The personal statements were reviewed by the
steering group.
2.2 Declarations of interest and management of conflicts of interest
All GDG members, peer reviewers and systematic review
team members were requested to complete the
declaration-of-interest form prior to the evidence-review
process for guideline development. Invitations to
participate in the GDG meeting were sent only after the
declarations of interest had been reviewed and
approved. These were reviewed by the responsible
technical officer at WHO – in this case the director of
the Department of Ageing and Life Course – and, when
necessary, legal counsel. The group composition was
finalized after this process. Annex 2 gives a summary of
relevant declarations of interest.
The declarations were once more assessed for potential
conflicts before the meeting in Geneva. The members
who were involved in conducting either primary research
or systematic reviews that would relate to the
recommendations did not participate in the formulation
of any recommendations themselves. The majority of the
members had no major conflicts of interest. Minor
conflicts of interest, of which there were two cases,
were managed individually by restricting participation at
relevant stages of the GDG meeting. All decisions were
documented (see Annex 2).
2.3 Identifying, appraising and synthesizing available evidence
The scope of the guidelines and questions (Annex 3)
were defined. A total of nine PICO (population,
intervention, comparison group, outcomes)
questions (23) were formulated by the GDG and
steering group. Outcomes were rated by GDG
members and external experts according to the
importance of each outcome from the perspectives of
older people and service providers, as not important
(rated 1–3), important (4–6), or critical (7–9). Outcomes
rated as critical were selected for inclusion into the
PICO analysis. The GDG engaged in regular
communications by email and discussions by
teleconference.
When formulating the scoping questions and conducting
the reviews, the focus was on evidence that applied
specifically to older people who were frail or care-
dependent or had priority conditions, and on
Guideline development process 2
6 Integrated care for older people
interventions that could be used by non-specialist health
workers in community settings or primary health care. The
steps that were taken for evidence retrieval, assessment
and synthesis are summarized in Annex 4. Further detail
on the review methods and available evidence is
summarized in the evidence profiles supporting these
guidelines. The evidence profiles used the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) methodology (24) followed by the
WHO guidelines handbook, and the profiles are available
at the WHO web pages for ICOPE (http://www.who.int/
ageing/health-systems/icope). The search strategy and
methods of quality assessment and appraisal are included
in each profile. This GRADE methodology for evidence-
based medicine was also used to formulate the
recommendations on the interventions, by providing a
rating of the overall quality of evidence arising from each
systematic review. All of the recommendations were
based on direct evidence and analysis of quantitative
data.
2.4 Consensus decision-making during the guideline development group meeting
The GDG met at the WHO headquarters in Geneva,
Switzerland, 24–26 November 2015. The evidence
reviews had been sent out in advance and were
presented in a summarized version during the meeting.
The GDG members discussed the evidence, clarified any
points and interpreted the findings, to develop
recommendations based on the draft prepared by the
WHO Secretariat. The GDG then proceeded with
deliberations and considered the relevance of the
recommendations for older people based on:
• the balance of benefit and harm of each intervention;
• values and preferences of older people;
• costs and resource use;
• acceptability of the intervention to health care providers in low- and middle-income countries;
• feasibility of implementation;
• impact on equity and human rights. To evaluate the values and preferences of older people
and the acceptability of proposed interventions to health
workers, no formal surveys were carried out; the
discussion and assessment of these domains instead
relied on the combined expertise and observations of
the GDG members. Similarly, no formal cost-
effectiveness studies were undertaken; again the GDG
members informed the assessments of resource
constraints based on their knowledge and experience.
Taking into account all of the above considerations, it
was agreed that if a recommendation would be of
general benefit, it would be rated as strong. If,
however, there were caveats about its benefits in
different contexts, and/or the quality of evidence was
less robust, the recommendation would be rated as
conditional. In the event of a disagreement, the chair
and the methodologist would ascertain whether the
dispute was related to the interpretation of the data or
to the way that the recommendation was formulated. If
a consensus agreement was not reached, the GDG
members agreed to a simple majority vote (51%/49%),
in which voting for this decision was by raised hands.
GDG members reserved the right to have any
objections recorded. Excluded from voting were any
WHO staff members present at the meeting and any
technical experts involved in the collection and review
of the evidence.
The GDG reached a consensus agreement on the
13 recommendations and ratings given in this
document. At the voting stage for recommendations
on cognitive training and respite care, these further
two were not supported due to insufficient evidence.
2.5 Document preparation and peer review In addition to the GDG members, four peer reviewers
provided expert input from specialized fields –
psychiatry, nutrition, physical therapy and geriatrics. A
preliminary version of these guidelines and the evidence
profiles prepared by WHO staff and the GDG were
circulated to the peer reviewers and the WHO steering
group. All inputs and remarks from reviewers were
discussed and agreed with the GDG by email.
Additionally, peer reviewers were asked to rate the
quality of the guidelines using a slightly modified version
of the tool, Appraisal of Guidelines for Research and
Evaluation (AGREE II). The original AGREE II tool lists 23
key items in the following domains: scope and purpose,
stakeholder involvement, rigour of development, clarity
of presentation, applicability, and editorial
independence (25). The reviewers’ total AGREE II scores
ranged from 22 to 154, and the average was 122.2.
7 Evidence and recommendations
Box 1: WHO guidelines and resources related to ICOPE
Mental Health Gap Action Programme (mhGAP) – mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0 (2016): http://www.who.int/mental_health/mhgap/mhGAP_ intervention_guide_02
Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings (2010): http:// www.who.int/nmh/publications/essential_ncd_interventions_ lr_settings.pdf
Guidelines for hearing aids and services for developing countries (2004): http://www.who.int/pbd/deafness/en/ hearing_aid_guide_en.pdf
Global recommendations on physical activity for health (2010): http://www.who.int/dietphysicalactivity/factsheet_ recommendations
Evidence and recommendations 3 Most of the conditions selected for these integrated
care for older people (ICOPE) guidelines share the same
underlying factors and determinants. It may be
possible to prevent or delay the onset of losses in
intrinsic capacity through a unified approach to
modifying a set of predisposing factors. For example,
highly intensive strength training is the key
intervention necessary to prevent and reverse mobility
impairments, but it also indirectly protects the brain
against depression and cognitive impairment, and
prevents falls. Nutrition enhances the effects of
exercise and has a direct impact on increasing muscle
mass and strength.
It is therefore necessary to implement these guidelines
using an older person-centred and integrated
approach. The recommendations are specific to the
community setting, but many are also applicable to
health care facilities.
The rationale and evidence base for the ICOPE
approach has been described previously in the WHO
World report on ageing and health (1).
Providers must ensure the following.
1. The assessment of individual impairments/declines
in capacity is used to inform the development of a
comprehensive care plan, and all domains are
assessed together.
2. Interventions to improve nutrition and encourage
physical exercise are included in most of the care
plans, and all the interventions needed are delivered
in conjunction with each other.
3. The presence of any impairment/decline in capacity
always triggers an urgent referral for medical
assessment of the associated disease (examples
being hypertension, diabetes, chronic obstructive
pulmonary disease, and dementia). WHO has
developed clinical guidelines to address most of the
relevant chronic diseases, and every health care
provider should have access to these (Box 1).
The ICOPE guidelines are organized into three modules.
• Module I: Declining physical capacities, including mobility loss, malnutrition, and visual impairment
and hearing loss, as well as declines in mental
capacities, such as cognitive impairment and
depressive symptoms.
• Module II: Geriatric syndromes associated with care-dependency in older age, including urinary
incontinence and risk of falls.
• Module III: Caregiver support.
8 Integrated care for older people
3.1 Module I: Declining physical and mental capacities
3.1.1 Mobility loss
Mobility is an important element of an older person’s
physical capacity. The loss of muscle mass and muscle
strength, decreased flexibility and problems with
balance can all impair mobility. Mobility impairment is
found in 39% of people over 65 years of age, which is
more than three times higher than among the
working population (26). Mobility loss can be
detected and its progression stopped or slowed if
appropriate exercise interventions are instigated early
in the process (27).
Considerations for recommendation 1
• The effects of exercise can be enhanced by combining it with increased protein intake and
other nutritional interventions.
• Consult a physical therapist or specialist, if available, before recommending exercise for older
people.
• Refer for investigations into, and treatment of, associated underlying diseases, such as arterial
and pulmonary disease, frailty and sarcopenia.
• Consider tailored, simple and less structured exercise programmes for older adults with
limitations in cognitive function. For older people
with severely reduced capacity, advise chair- and
bed-based exercise training as a starting point.
• Environmental characteristics associated with older people gaining more physical activity include
providing safe spaces for walking, ensuring easy
access to local facilities, goods and services,
seeing people of a similar age exercising in the
same neighbourhood, and regular participation in
exercise with friends and family.
• The effects of multimodal exercise interventions are enhanced when prescribed in association with
self-management support. Self-management
support also improves adherence.
• Multimodal interventions are a combination of different modes of exercise (aerobic, resistance,
flexibility, balance), with an emphasis on
important muscle groups and performed in a
functional manner. Older adults should be offered
guidance on the physical activity recommended
for their age and health conditions. WHO provides
recommendations that consider different starting
points and levels of capacity for physical activity to
maintain health (see http://www.who.int/
dietphysicalactivity/factsheet_
recommendations) (27).
Supporting evidence for recommendation 1
A systematic search identified 130 reviews, 11 of which
served as the basis for the primary findings summarized
below.
• Further detail on the supporting evidence is in the Evidence profile: mobility loss, available at http://
www.who.int/ageing/health-systems/icope.
Seven reviews from high-income countries used a
multimodal exercise programme of progressive muscle
strengthening or generic strength training, balance
retraining exercise, aerobic training and flexibility
training. Pooled data from the trials included in these
reviews indicated that this intervention significantly
improved critical outcomes, including muscle strength
of the lower extremity (10 trials, 1259 participants),
balance (16 trials, 1313 participants), gait speed (15
trials, 1543 participants), chair stand test score (9 trials,
827 participants), overall physical function (9 trials, 976
participants) and activities of daily living (7 trials, 551
cases). The overall quality of evidence was rated as
moderate as the results were consistently beneficial for
all critical outcomes and the GDG considered that
several of the critical outcomes would individually
suffice to support a recommendation for the
intervention.
Multimodal exercise, including progressive strength resistance training and other exercise components (balance, flexibility and aerobic training), should be recommended for older people with declining physical capacity, measured by low gait speed, grip strength and other physical performance measures.
Quality of the evidence: moderate Strength of the recommendation: strong
Recommendation 1
9 Evidence and recommendations
Eleven trials, reported in four reviews, investigated the
benefit of progressive resistance training in older
people with mobility impairment. Evidence suggests
that progressive resistance training improves muscle
strength of the lower extremity (8 trials, 655
participants) and chair stand test scores (2 trials, 38
participants). The overall methodological quality rating
was moderate for the muscle strength outcome and
low for the chair stand test. Progressive resistance
training had no effect on other critical outcomes
(balance, gait speed, Timed Up and Go score, overall
physical function and activities of daily living). In
addition, three trials of t’ai chi training showed a
significant benefit in terms of improving balance (348
cases), but no effect on the gait speed, chair stand
score, activities of daily living or the number of falls.
The overall methodological quality rating was low for
the balance outcome.
Rationale for recommendation 1
Moderate-quality evidence supports the use of
multimodal exercise training to improve the functional
outcomes in older adults with mobility impairment. The
GDG recognized a greater effect on critical functional
outcomes for multimodal exercise. The effects and
quality of evidence for stand-alone progressive
resistance training and t’ai chi were not considered
sufficient for incorporation into the recommendation.
Adverse events reported in a small proportion of trials
were reviewed. The most commonly reported events
were muscle soreness and joint pain. Very few trials
reported serious adverse events, such as fracture,
hospitalization or death. No clear relationship was
noted between severe events and exercise: similar
events were reported in the intervention and control
groups.
The GDG recognized the additional cost associated
with the scaling-up of supervised exercise training for
older people. The GDG felt that the programme cost
could be reduced through minimal training for family
members and the provision of self-help guides.
The GDG agreed that multimodal exercise was critical to
maintaining physical capacity in older people, and that it
would be acceptable to them, to family members and to
other stakeholders. Based on the moderate quality of
the evidence, the widespread acceptability of exercise
and the potential opportunities to shift health care tasks,
the GDG made a strong recommendation.
3.1.2 Malnutrition
Ageing is accompanied by physiological changes that
can have a negative impact on nutritional status and,
consequently, intrinsic capacity. Sensory impairments (a
decreased sense of taste and smell, for example), poor
oral health, isolation, loneliness and depression –
individually or in combination – all increase the risk of
malnutrition in older age. Ageing is associated with
changes in body composition; after the age of 60 years,
there is a progressive decrease in body weight that
results mainly from a decrease in fat-free mass and lean
mass, and an increase in fat mass. Stable body weight
overall masks such age-related changes in body
composition. Older people who do not consume enough
protein are at increased risk of developing sarcopenia,
osteoporosis and impaired immune response.
Considerations for recommendation 2
• Nutritional assessments should be specific to the older person and include nutritional history,
records of food intake or 24-hour dietary recall,
physical examination with particular attention to
signs of inadequate nutrition or
overconsumption, and specific laboratory tests if
applicable. There are several tools available to
assess nutritional status in older people (28, 29).
• Assessment of muscle mass and muscle strength must be included in the assessment of
nutritional status.
• Dietary counselling to ensure a healthy diet that provides adequate amounts of energy, protein
and micronutrients should be encouraged for all
older people, including those who are at risk of
or affected by undernutrition.
• It is important to consider specially formulated supplementary foods (in ready-to-eat or milled
form), which are modified in their energy density,
Oral supplemental nutrition with dietary advice should be recommended for older people affected by undernutrition.
Quality of the evidence: moderate Strength of the recommendation: strong
Recommendation 2
10 Integrated care for older people
protein, fat or micronutrient composition, to help
meet the nutritional requirements of older
people.
• Mealtime interventions (including family-style meals and social dining) are important
approaches for managing undernutrition in older
people. Consider family-style meals or social
dining for older people living alone or who are
socially isolated.
• Protein absorption decreases with age. Low protein intake is associated with loss of lean
body mass, and standard protein intake may not
be sufficient for older people.
• Refer older people with evidence of potentially serious underlying physical illness (gross
cachexia, rapid weight loss, obstruction or
difficulty swallowing, vomiting, chronic
diarrhoea, abdominal pain or swelling) for
medical review by a physician or specialist.
Supporting evidence for recommendation 2
Our search strategy identified three systematic reviews
to inform these recommendations (30–32). We conducted an independent search strategy in 2015 to
update the 2009 review (31) and identified 29 additional
trials.
• Further detail on the supporting evidence is in the Evidence profile: malnutrition, available at http://
www.who.int/ageing/health-systems/icope.
The search strategy involved older people who were at
risk of or affected by undernutrition. All but two of the
trials were conducted in high-income countries. The
majority of the trials were in hospital settings or
long-term care facilities (nursing, retirement or
residential homes). The definition of undernutrition
varied in the trials. The majority applied an
anthropometric measure – typically body mass index
(BMI) – as a nutritional status indicator, and compared it
against WHO cut-off values (where underweight is
below 18.50 kg/m2). The assessed interventions were
aimed at improving the intake of protein and energy
using only the normal oral route. Protein was provided
together with non-protein energy sources such as
carbohydrate and fat, and with or without added
minerals and vitamins. The types of intervention
considered included supplements in the form of
commercial sip feeds; milk-based supplements;
fortification of normal food sources; addition of fluid
milk (low-fat or fat-free) to the usual daily consumption
of dairy products; commercial nourishing drink made up
with either milk or water; high-protein and high-calorie
feeding supplementary to the hospital diet; commercial
supplements or formulated meal-replacement
commercial drinks in addition to meals; and other
specially formulated nutrition products. Most
supplementation trials aimed to provide, per serving,
300–400 kcal, 12–20 g of protein, and additional
vitamins and minerals.
The evidence indicated that the consumption of oral
supplemental nutrition significantly reduced mortality
compared with people on placebo or usual care. In a
subgroup analysis, the pooled data from trials conducted
in community settings showed no effect on mortality,
whereas the treatment effect on mortality remained
significant in trials performed in hospital and long-term
care settings.
Weight gain, rated as a critical outcome, was reported in
70 trials. These data showed that the intervention
improved weight gain for older adults affected by
undernutrition. In the subgroup analysis, a significant
benefit was indicated in improving weight gain in these
older people in trials conducted both in the community
setting and in the hospital or long-term care setting.
Rationale for recommendation 2
Moderate-quality evidence showed that administration
of oral supplemental nutrition plus dietary advice
could prevent mortality and improve weight gain in
older people affected by undernutrition. The GDG
reviewed the adverse effects associated with this
recommendation. Fifteen trials reported adverse effects
Box 2: Oral supplemental nutrition
Oral supplemental nutrition is the provision of additional high-quality protein, calories and adequate amounts of vitamins and minerals tailored to the individual’s needs assessed by a trained health care professional. The assessment allows for the best source and vehicle for these nutrients to be defined, whether through the use of supplements, nutrient-rich foods, or specialized commercial or non-commercial nutritional formulations.
11 Evidence and recommendations
in both treatment and control groups, but only four of
these (two hospital studies, one nursing home study and
one community study) provided a systematic evaluation
and comparison of adverse effects in the treatment and
control conditions. Common side-effects reported in the
studies were gastrointestinal symptoms, nausea and
diarrhoea. A higher number of adverse effects were
reported in studies conducted in hospital settings; this
may reflect the baseline severity of the undernutrition,
the intensity of supplementation, the presence of
comorbid acute illness or, possibly, increased monitoring
of adverse effects. Other trials reported a prevalence of
adverse effects in both the intervention and control
groups, and the majority of these studies reported no
between-group differences in adverse effects. The GDG
therefore concluded that the potential risks associated
with nutritional intervention were small.
Adherence to the nutritional interventions was discussed
in detail. The GDG suggested that oral supplemental
nutrition may be acceptable to many older people, and
would assist those at risk of, or affected by,
undernutrition to meet their nutritional requirements. In
conclusion, the GDG agreed that these
recommendations would be appreciated by older adults
and acceptable to key stakeholders.
The implementation of this recommendation may have
major resource implications, particularly in the training of
staff members. However, in many low- and middle-
income countries, community health workers deliver
nutritional interventions for children affected by
undernutrition and for pregnant mothers. Based on this
experience, the GDG concluded that training could be
undertaken for existing human resources to implement
these recommendations.
The GDG considered that if recourse to the provision of
supplemental nutrition or specific food products was
necessary to increase an individual’s dietary intake of
protein, energy or vitamins and minerals, this should
always be combined with dietary advice. Provision of
dietary advice will aid an older person’s understanding
of the need for oral supplemental nutrition and will
ensure that their dignity and human rights are respected.
Based on the evidence, the GDG made a strong
recommendation in favour of oral supplemental nutrition
for older people affected by undernutrition.
The GDG also considered the evidence for increasing
dietary intake and mealtime interventions. Although
there was enough evidence about their benefits to
support a recommendation, the GDG decided that,
due to the generic nature of these two interventions, it
was more appropriate not to issue a recommendation.
3.1.3 Visual impairment
Ageing is frequently associated with loss of vision that
limits physical performance and activities in daily life.
Over half of older adults with impaired vision
experience improvements through non-invasive
methods, mainly corrective lenses. Some 79% of
people over 60 years of age and 90% of people over
70 have cataract, representing the single-most
important cause of vision loss (1). These people go
back to full visual function with cataract surgery. Yet
many older people living in low-income countries have
never had even an eye examination, with little
opportunity for accessing eye-care services.
Community case finding and the immediate provision
of eye care or assisted referral for cataract surgery
could improve physical capacity and functional ability
in older people.
Considerations for recommendation 3
• At the primary health care level, visual screening can be performed using a Snellen chart to screen
for visual acuity.
• It is important to improve public awareness and generate demand for services through regular
community outreach activities.
• Promote case finding at the primary and community care settings, where health care
personnel such as community health workers can
be trained to screen for visual acuity.
• Establish comprehensive eye-care services, so that refraction services with the provision of
Older people should receive routine screening for visual impairment in the primary care setting, and timely provision of comprehensive eye care.
Quality of the evidence: low Strength of the recommendation: strong
Recommendation 3
12 Integrated care for older people
suitable correction tools are available at the
primary health care level.
• Specifically, provide spectacles that are new, of high quality, accessible and affordable in
low-income settings.
• The most common causes of vision impairment in older people include presbyopia, cataract,
glaucoma, diabetic retinopathy and age-related
macular degeneration. Older people found to
have a visual impairment should therefore be
assessed for these medical conditions.
• Older people who have had diabetes for five years or more must be referred for an
assessment with an ophthalmologist.
Additionally, it is advisable that people who are
at risk of glaucoma (including people of African
descent and people with a positive family
history), who are at risk of diabetes, or who have
severe myopia undergo periodic assessment by
an ophthalmologist. The WHO publication,
Prevention of blindness from diabetes
mellitus (33) is available at http://www.who.
int/diabetes/publications/prevention_
diabetes2006.
• Refer to eye-care practitioners or occupational therapists who have expertise in environmental
modifications (working with colour and contrast
in the environment of the person with low vision)
and can teach activities of daily living and skills,
such as washing clothes.
Supporting evidence for recommendation 3
Evidence was compiled from three systematic reviews: an
updated systematic review that identified five trials of
screening and referral, an updated systematic review that
identified two trials of screening plus provision of
immediate eye care, and an updated systematic review
that identified three trials of expedited cataract surgery.
• Further detail on the supporting evidence is in the Evidence profile: visual impairment, available at http://
www.who.int/ageing/health-systems/icope.
No new trials have been identified in a WHO update of a
systematic review that was published in 2006 on
screening and referral, which found five trials (35). For
these guidelines, results from the three initial systematic
reviews therefore comprise the evidence base. In it,
pooled data from five trials of 3494 participants
indicated that there was no evidence to suggest that
visual screening alone could improve visual function in
older people. The authors concluded that the reasons for
the lack of benefit were high loss to follow-up,
contamination of the intervention, similar frequencies of
vision disorder detection and treatment in both groups,
the use of one screening question to identify people for
further testing, and a low uptake of recommended
interventions.
A review that identified two trials of visual screening
combined with immediate referral for correction of
refractive errors revealed evidence of beneficial effects. In
the first of the two trials, older people in the intervention
group received prescriptions and vouchers for free
eyeglasses (36), while participants in the second study
were immediately provided with corrective glasses (37).
The participants in the first trial were people 65 years of
age and over living in the community, whereas the second
trial recruited nursing home residents 55 years of age and
over. In both trials, visual functioning improved in the
immediate-treatment groups.
The systematic review that identified three trials
examining the effectiveness of expedited cataract surgery
found substantial improvements in vision for older people
who had undergone expedited surgery, compared with
outcomes for people in the routine surgery or waiting list
groups (38–40).
Rationale for recommendation 3
The GDG acknowledged the higher prevalence of
vision impairment in older people compared with
Box 3: Definitions of low vision
The following definitions of low vision are in use (34):
• Defined by WHO: visual acuity less than 6/18 in one eye and equal to or better than 3/60 in the better eye with best correction.
• In use by low-vision services or care: impairment of visual functioning for the person even after treatment and/or standard refractive correction, and a visual acuity of less than 6/18 to light perception, or a visual field less than 10 degrees from the point of fixation, but with ability or potential ability to use vision for planning and/or executing a task for which vision is essential.
13 Evidence and recommendations
younger, and the enormous individual and societal
burden associated with untreated vision conditions.
The group considered the limited supportive evidence
for the effects on self-reported visual improvement
following screening and referral (35). The GDG agreed
that the use of screening as a stand-alone intervention
was not warranted and that it should be combined
with immediate provision of indicated eye care to
improve the visual acuity of older people with visual
impairment. In addition, the large beneficial effects of
cataract surgery observed in three trials was noted by
the GDG in support of the provision of cataract
surgery, when indicated. None of the trials reviewed
reported any adverse consequences associated with
screening for vision plus timely provision of care. The
GDG recognized the high acceptability and feasibility
of this screening and care. The vision-care experts in
the GDG mentioned that in many countries, including
low- and middle-income ones, there were national
programmes for the management of blindness in
place, in which professionals trained in the early
identification of avoidable blindness performed vision
screening. This screening was focused largely on
children, however, while many older people
experienced difficulties accessing such screening and
timely provision of care. The GDG felt that screening
coupled with provision of indicated eye care might
increase equity in this field.
Given the minor variability in values and preferences,
the feasible and acceptable nature of the intervention,
and the potential for benefits to greatly outweigh
harms, especially in high-burden countries, the GDG
made a strong recommendation despite the low
quality of the evidence.
3.1.4 Hearing loss
Untreated hearing loss affects communication and can
contribute to social isolation and loss of autonomy,
with associated anxiety, depression and cognitive
impairment. Despite its considerable individual and
social implications, hearing loss is largely undetected
and undertreated in older people. Yet this common
limitation in intrinsic capacity can generally be
managed effectively. Simple interventions and
adaptations for hearing loss include fitting hearing
aids, environmental modifications, and behavioural
adaptations that include reducing background noise
and using simple communication techniques, such as
speaking clearly.
Considerations for recommendation 4
• Community awareness about hearing loss and the positive benefits of audiological rehabilitation in
older people, through community case finding and
outreach activities, should be promoted.
• Health care professionals should be encouraged to screen older adults for hearing loss by periodically
questioning them about their hearing. Audiological
examination, otoscopic examination and the
whispered voice test are also recommended.
• Hearing aids are the treatment of choice for older people with hearing loss, because they minimize the
reduction in hearing and improve daily functioning.
• Medications should be reviewed for potential ototoxicity.
• People with chronic otitis media or sudden hearing loss, or who fail any screening tests should be
referred to an otolaryngologist.
• Additional guidance can be found in the WHO Guidelines for hearing aids and services for developing
countries (41), available at http://www.who.int/pbd/
deafness/en/hearing_aid_guide_en.pdf.
Supporting evidence for recommendation 4
Evidence for this recommendation was obtained by
reviewing two randomized controlled trials. Both trials
demonstrated the benefit of screening and immediate
provision of hearing aids in older adults. The earlier of
the two found that immediate provision of hearing aids
was associated with statistically significant improvements
in the hearing-related quality-of-life score the Hearing
Handicap Inventory for the Elderly (HHIE), and in the
Quantified Denver Scale of Communication Function
(QDS) score (42). In the second trial both hearing aid
groups experienced greater improvements in hearing-
related outcomes compared with the no-treatment and
Screening followed by provision of hearing aids should be offered to older people for timely identification and management of hearing loss.
Quality of the evidence: low Strength of the recommendation: strong
Recommendation 4
14 Integrated care for older people
assistive-listening device groups (43). The mean
improvement in HHIE scores in this trial was small for
control patients (2.2 points) and those who received an
assistive listening device (4.4 points), larger for patients
who received a conventional device (17.4 points), and
considerable for patients who received a programmable
device (31.1 points).
• Further detail on the supporting evidence is in the Evidence profile: hearing loss, available at http://
www.who.int/ageing/health-systems/icope.
Rationale for recommendation 4
The GDG considered there was low-quality evidence
supporting the use of screening and provision of hearing
aids as a way to improve critical hearing-related outcomes
for older people. In addition to the evidence, however, the
GDG also considered issues such as the opportunity costs
and usefulness of potential interventions given the very
high prevalence of, and the enormous societal
implications associated with, undiagnosed and untreated
hearing loss; worldwide, one third of older people live
with some degree of hearing loss.
The GDG members thus agreed that the benefits of the
intervention outweighed the disadvantages and costs.
Screening and use of hearing aids does not seem to harm
individuals, high-quality hearing aids can now be fitted at
an affordable cost, and most older people do not object
to being assessed. Based on the acceptability, feasibility
and increasing affordability of hearing aids – coupled with
the potentially large beneficial effects afforded to older
people living in high-burden countries if they are able to
engage and communicate effectively within their
communities – the GDG decided to issue a strong
recommendation despite the low-quality evidence.
3.1.5 Cognitive impairment
Cognitive impairment is a strong predictor of functional
disability and the need for care among older people.
Mild cognitive impairment increases the risk of
developing dementia, and the available evidence
suggests that an average five-year postponement of the
age of onset would reduce the prevalence of dementia
by half (44). Cognitive stimulation therapy, such as
participation in a range of activities aimed at improving
cognitive and social functioning, is a critical strategy to
prevent and reverse declining cognitive capacity and,
consequently, to prevent functional disabilities and care
dependency in older age.
Considerations for recommendation 5
• Assessment for cognitive function can be performed using any locally validated tool.
• In the absence of standard assessment, the person, and also someone who knows them well, should
be asked about problems with memory,
orientation, speech and language, and any
difficulties in performing key roles and activities.
Memory, orientation and language should be
assessed.
• Cognitive stimulation could be delivered in short sessions. In high-income countries, it is usually
administered by psychotherapists. Some
characteristics of the intervention such as duration
or frequency could, however, be adapted for each
setting, and it could be administered by suitably
trained and supported non-specialists.
• It is important to encourage family members and caregivers to provide older people with regular
orientation information (day, date, time, weather,
names of people, and so on), to help them remain
orientated in time and place. They can use materials
such as newspapers, radio and television
programmes, family albums and household items to
promote communication, orientate the person to
current events, stimulate memories and enable
them to share and value their experiences.
• Impairment in cognitive function may be associated with memory deficits and difficulties managing
instrumental activities of daily living such as finances
and shopping, and with impaired social function.
Cases should be referred for medical assessment.
• More guidance on dementia can be found in the WHO mhGAP intervention guide (45), available at
http://www.who.int/mental_health/mhgap/mhGAP_
intervention_guide_02.
Cognitive stimulation can be offered to older people with cognitive impairment, with or without a formal diagnosis of dementia.
Quality of the evidence: low Strength of the recommendation: conditional
Recommendation 5
15 Evidence and recommendations
Supporting evidence for recommendation 5
Evidence on the effectiveness of cognitive stimulation
interventions for older adults with cognitive impairment
was extracted from one systematic review (44). In this
study, interventions were typically delivered in day-care
or long-term care settings, and involved participants
with dementia or mild cognitive impairment, or both.
The review analysed pooled data from 17 trials:
12 studies (810 participants) assessed cognitive
impairment using the Mini Mental State Examination
(MMSE) while the other five trials assessed cognitive
function using the Alzheimer’s Disease Assessment Scale
– Cognitive subscale (ADAS-Cog). Evidence from all of
these trials showed significant improvement in cognitive
function after the intervention. The overall quality of the
evidence was low. New randomized controlled trials are
needed to test the efficacy of different types of
cognitive-based interventions that exclusively target
older adults with cognitive impairment.
• Further detail on the supporting evidence is in the Evidence profile: cognitive impairment, available at
http://www.who.int/ageing/health-systems/icope.
Rationale for recommendation 5
Low-quality evidence supports the use of cognitive
stimulation interventions (of any form) to improve
cognitive function in older people with mild cognitive
impairment and dementia. The GDG recommends that
health care professionals provide these interventions to
people who are eligible. The GDG identified low-
quality evidence that the intervention improved
important health outcomes, and concluded that the
benefits outweighed the adverse effects. The
intervention is non-invasive and no trial reported any
harms associated with cognitive stimulation. Variability
in values and preferences was noted to be minor, and
the intervention was considered feasible and
acceptable. Resource requirements for delivery of
cognitive stimulation interventions would initially be
considerable, but the GDG argued that adaptation of
the intervention for specific settings, and investment in
training of non-specialists, would potentially discount
future costs. The strength of this recommendation is
conditional, due to the low quality of the evidence –
most trials involved older people who had dementia,
and the effects of cognitive stimulation interventions in
those with mild cognitive impairment without dementia
remains unclear.
3.1.6 Depressive symptoms
Depressive symptoms (or sub-threshold depression)
apply to older adults who have two or more
simultaneous symptoms of depression present for most
or all of the time, for at least two weeks in duration, but
who do not meet the criteria for a diagnosis of a major
depressive disorder. This is an important condition that
affects between 6% and 10% of older adults in primary
care settings, 30% in medical and long-term care
settings, and is associated with declining intrinsic
capacity (46).
Box 4: How to identify cognitive impairment • Assessment for cognitive function can be performed using any
locally validated tool.
• In the absence of standard assessment: (a) assess memory by asking the person to repeat three common words immediately, then again 3 to 5 minutes later, (b) assess orientation to time by asking the time of day, day of week, season, and year, and assess orientation to place by asking the person where they are being tested, or where the nearest market or store is to their home, and (c) test language skills by asking the person to name parts of the body and to explain the function of physical items (for example, “What do you do with a hammer?”).
• Confirm any cognitive deficit with a family member or someone else who knows the person well.
More detail is found in the WHO mhGAP intervention guide (45), available at http://www.who.int/mental_health/mhgap/ mhGAP_intervention_guide_02.
Older adults who are experiencing depressive symptoms can be offered brief, structured psychological interventions, in accordance with WHO mhGAP intervention guidelines, delivered by health care professionals with a good understanding of mental health care for older adults. Quality of the evidence: very low Strength of the recommendation: conditional
Recommendation 6
16 Integrated care for older people
Considerations for recommendation 6
• Older people can experience psychological difficulties consistent with the symptoms of depression but
without these necessarily meaning they have
moderate-to-severe depression. When assessing older
people, it is important to assess whether the person
has depressive symptoms, but also if these are
associated with social isolation, and whether the
person has difficulties in day-to-day functioning due
to depressive symptoms.
• Cognitive impairment and dementia may be associated with depressive symptoms and must be
assessed. People with dementia often present with
complaints of mood or behavioural problems, such as
apathy, loss of emotional control, or difficulties
carrying out usual work or domestic or social activities.
• The management and assessment of depressive symptoms is covered by the WHO mhGAP
intervention guide (45) (within the module for ‘Other
significant emotional or medically unexplained somatic
complaints; see Box 5).
• Older people who qualify for a diagnosis of depressive disorder should be advised and treated as
recommended in the mhGAP guidelines.
• Physical exercise should be considered as an adjunct to structured psychological treatments to improve
intrinsic capacity in older people (see the guidance in
section 3.1.1 on mobility loss).
Supporting evidence for recommendation 6
Evidence on the benefit of psychological intervention for
managing depressive symptoms in older adults was
extracted from two systematic reviews (47, 48). All the
trials reviewed were conducted in high-income countries
and administered by trained mental health care
professionals.
Pooled data from six trials (826 older adults) that used
cognitive behavioural therapy, problem-solving therapy
and life-review therapy indicated that these interventions
considerably reduced depressive symptoms in older
adults. The overall quality of the evidence was low.
Another review examined the effectiveness of behavioural
activation specifically in reducing depressive symptoms in
adults. However, only three of the included trials recruited
older adults. Evidence from these trials (102 older adults)
showed that behavioural activation significantly reduced
depressive symptoms in the intervention group. The
overall quality of the evidence was very low.
• Further detail on the supporting evidence is in the Evidence profile: depressive symptoms, available at
http://www.who.int/ageing/health-systems/icope.
Rationale for recommendation 6
Very low-quality evidence supports the use of
psychological interventions (cognitive behavioural
therapy, problem-solving therapy, interpersonal
counselling, behavioural activation therapy and life-
review therapy) to reduce depressive symptoms in older
adults. No trials reported harms associated with these
interventions. In the absence of any specific harms, the
GDG concluded that these interventions were likely to
have limited potential for harm. The administration of
behavioural activation is a relatively unsophisticated
intervention that can be learned more quickly than
Box 5: Summary information for treatment of depression
Brief, structured, psychological treatment: • Interpersonal therapy and cognitive behavioural therapy
(CBT) (including behavioural activation), and problem- solving treatment should be considered as psychological treatment of depressive episode/disorder in non-specialized health care settings if there are sufficient human resources (supervised community health workers, for example). In moderate and moderate-to-severe depression, problem- solving treatment should be considered as adjunct treatment.
• A problem-solving approach should be considered in people with depressive symptoms (in the absence of a depressive episode disorder) who are in distress or have some degree of impaired functioning.
• Psychological treatment based on CBT principles should be considered in repeat adult help-seekers with medically unexplained somatic complaints who are in substantial distress and who do not meet the criteria for depressive episode/disorder.
More detail and further recommendations are in the WHO mhGAP intervention guide (45), available at http://www.who.int/mental_health/mhgap/mhGAP_ intervention_guide_02.
17 Evidence and recommendations
most other evidence-based psychological treatments.
The intervention has been studied mainly as a multiple-
session intervention performed by specialists, however,
which may not generalize to non-specialized health
care and carries considerable resource implications.
Nonetheless, the intervention could be modified into a
brief intervention as an adjunct treatment or as part of
a first step in a comprehensive care approach in
primary health care. Although the evidence specifically
for older people is scarce, WHO has comprehensive
tools and guidelines to manage depressive symptoms in
adults. Given that depression is associated with a
severe decline in functional ability among older people
– and that a recommendation in favour of the provision
of brief psychological interventions would be consistent
with the existing WHO mhGAP recommendation for
depression (45) – the GDG concluded that the benefits
outweighed the harms. In view of the very low quality
of evidence and the possible lack of generalizability to
all community settings, the GDG issued a conditional
recommendation for the treatment of depressive
symptoms in older adults.
3.2 Module II: Geriatric syndromes
3.2.1 Urinary incontinence
Urinary incontinence – involuntary leakage of
urine – affects about a third of older people
worldwide (49–51). Continence depends not only on
lower urinary tract function but also on intact mobility,
cognition and motivation. Urinary incontinence has
important medical repercussions and is associated with
decubitus ulcers, sepsis, renal failure, urinary tract
infections and increased mortality. Psychosocial
implications of incontinence include loss of self-esteem,
restriction of social and sexual activities, and
depression. Urinary incontinence is also a key
determinant of care dependency in older age.
Considerations for recommendations 7 and 8
• Urinary incontinence in older people is multifactorial and needs evaluation and treatment
that is not focused solely on the lower urinary tract.
Although an assessment of urinary incontinence can
be made by non-specialized health workers, full
evaluation is the responsibility of a medical
professional or clinician. The full assessment is
needed because of the multifactorial nature of
urinary incontinence in older people. The
examination should include cardiovascular,
abdominal and neurological systems as well as
assessment of mobility and cognition.
• An assessment of urinary incontinence includes the evaluation of fluid intake, medications, physical and
cognitive capacity (including mobility), and previous
urological surgeries.
• The single best question to ask when diagnosing urge incontinence is: “Do you have a strong and
sudden urge to void that makes you leak before
reaching the toilet?”
• A good question to ask when diagnosing stress incontinence is: “Is your incontinence caused by
coughing, sneezing, lifting, walking or running?”
• The person needs to be assessed for reversible causes of urinary incontinence, such as delirium,
infection, atrophic vaginitis, pharmaceutical causes
such as medication-induced urinary retention,
psychological disorder (depression), excessive urine
output (hyperglycaemia, for example), and stool
impaction.
• As a first-line treatment, provide advice on bladder training for a minimum of 6 weeks. Bladder training
involves advising the older person to follow a strict
schedule for bathroom visits. The schedule starts
with bathroom visits every 2 hours, but the time
between visits should be gradually increased to
improve bladder control.
7. Prompted voiding for the management of urinary incontinence can be offered for older people with cognitive impairment.
Quality of the evidence: very low Strength of the recommendation: conditional
8. Pelvic floor muscle training (PFMT), alone or combined with bladder control strategies and self-monitoring, should be recommended for older women with urinary incontinence (urge, stress or mixed).
Quality of the evidence: moderate Strength of the recommendation: strong
Recommendations 7 and 8
18 Integrated care for older people
• Pelvic floor muscle training (PFMT) strengthens the muscles that support the urethra and augment its
closure. Often used for stress urinary incontinence,
PFMT may help with urge leakage as well. Similar to
other muscle-strengthening regimens, PFMT is
based on controlled repetitions of high-intensity
contractions, held for as long as possible. A starting
regimen could be 3 sets of 10 contractions (with
adequate relaxation between each) repeated
2–3 times per week.
• Key to the success of PFMT is correct identification of the target muscles and appropriate motivation to
continue the programme.
Supporting evidence for recommendations 7 and 8
Five systematic reviews were identified, of which two
systematic reviews served as the basis for the primary
findings on prompted voiding and PFMT
interventions (52, 53).
7: Prompted voiding
Four of the reviewed trials were conducted in the
United States of America, and most of the participants
in these had moderate-to-severe cognitive impairment.
All except one of the trials recruited older adults with
urinary incontinence in nursing home settings. The
duration of the intervention ranged from 20 days to
32 weeks. The evidence showed that the prompted
voiding intervention significantly reduced the number
of incontinence episodes in 24 hours.
Data for self-initiated toileting outcomes were reported
in four trials, but only one provided sufficient data. All
of these trials showed a significant increase in
independent requests for the toilet as a result of the
prompted voiding intervention. The overall quality of
the evidence was low.
• Further detail on the supporting evidence for both prompted voiding and PFMT is in the Evidence
profile: urinary incontinence, available at http://
www.who.int/ageing/health-systems/icope.
8: Pelvic floor muscle training (PFMT)
Evidence for PFMT was derived primarily from five
randomized controlled trials that investigated the benefit
of PFMT compared with placebo or control. Two of
these trials were conducted in Brazil, two in Japan, and
one in the United States. The mean age of the study
participants ranged from 60.2 years to 76.6 years. All of
the trials recruited older women living in the community.
Participants’ perceived cure of urinary incontinence was
reported in three trials. The data showed that PFMT
significantly increased the perceived cure rate and
significantly reduced urinary incontinence symptoms.
The overall quality of the evidence for PFMT was low.
The benefit of PFMT when combined with bladder
control strategies, with or without biofeedback, has
been examined. All of the trials reviewed recruited older
adults living in the community, and the majority of the
participants had mixed urinary incontinence. The
combined intervention was administered at home and in
clinical settings. The mean age of the study participants
ranged from 65.4 years to 74.7 years. All except one of
the trials recruited only older women. The pooled data
from five trials (709 participants) indicated that this
intervention significantly reduced the number of
incontinence episodes over 6–24 weeks of follow-up. The overall quality of the evidence was moderate.
Rationale for recommendations 7 and 8
Low-quality evidence supports the use of prompted
voiding to reduce episodes of urinary incontinence
among older people with cognitive impairment. Urinary
incontinence is common among those with cognitive
impairment and increases the need for formal and
informal care. No trial has reported adverse effects
associated with prompted voiding interventions. All of
the included trials were conducted in high-income
countries in long-term care settings and the GDG
recognized that these interventions may be difficult to
implement in community settings reliant on the help of
family caregivers. Based on the low-quality evidence and
the potential challenges to implementation in
community settings, the GDG made a conditional
recommendation.
Low-quality evidence supports PFMT when used on its
own to reduce incontinence in older women with urinary
incontinence. When combined with bladder control
strategies and self-monitoring, the quality of evidence
increases to moderate in support of using PFMT. Urinary
incontinence has a profound impact on the older
person’s quality of life and functional ability, and
increases the need for care. No trial has reported
adverse effects associated with this intervention, and the
GDG considered that the potential for harm from PFMT
19 Evidence and recommendations
was likely to be low given the non-invasive nature of the
intervention. The GDG indicated that the
recommendation was likely to be valued by older
women with urinary incontinence, and that the
intervention was highly acceptable to health care
providers. Based on the moderate quality of the
evidence for the combined approach, and the minimal
harms, the GDG made a strong recommendation for
provision of PFMT both alone and in combination with
other strategies.
3.2.2 Risk of falls
Declining physical capacity in older people often
manifests in falls and fall-related injuries. Around one
third of people over 65 years of age and living in the
community have a fall each year, many of whom are
experiencing recurrent falls (54, 55). Falls are the leading
cause of hospitalization and injury-related death. Fatal
fall rates rise considerably to sharply with five-year
increases above 60 years of age (56). Accidental falls are
due to a combination of extrinsic (environmental) and
intrinsic (organ system abnormalities affecting postural
control) factors. Extrinsic factors include environmental
hazards such as loose rugs, clutter, poor lighting and
improper foot wear such as ill-fitting, floppy slippers.
Intrinsic factors include abnormalities in any of the
organ systems that contribute to postural control such
as sensory, musculoskeletal and central nervous system.
Older people can decrease their fall risk with exercise,
physical therapy, home-hazard assessments and
adaptations, and withdrawal of psychotropic
medications.
Considerations for recommendations 9–12
• Older people who present for medical attention because of a fall, report recurrent falls in the past
year, or demonstrate abnormalities of gait and/or
balance should be offered a comprehensive risk
assessment.
• A comprehensive assessment may include the following items: history of falls; gait, balance,
mobility and muscle weakness; osteoporosis risk;
fear of falling, vision impairment, cognitive
impairment, neurological examination; urinary
incontinence; home hazards; cardiovascular
examination; and medication review.
• Multimodal exercise, including progressive resistance training and other exercise components (balance,
flexibility and aerobic training) must be included in
every care plan for older people at risk of falls (see
Recommendation 1 on mobility loss).
• Identification of older people with visual impairment and their referral for interventions should be
implemented in any approach to prevent falls. To
prevent falls for older people with cataract, for
example, immediate surgery should be
recommended.
• Medication review by a trained health care professional, especially to reduce psychotropic
medication, has been shown to reduce falls. Older
people should be encouraged to reduce their use of
sleeping aids, including over-the-counter medication
containing diphenhydramine or other sedating
antihistamine. Benzodiazepines and antidepressants
have also been associated with falls.
9. Medication review and withdrawal (of unnecessary or harmful medication) can be recommended for older people at risk of falls.
Quality of the evidence: low Strength of the recommendation: conditional
10. Multimodal exercise (balance, strength, flexibility and functional training) should be recommended for older people at risk of falls.
Quality of the evidence: moderate Strength of the recommendation: strong
11. Following a specialist’s assessment, home modifications to remove environmental hazards that could cause falls should be recommended for older people at risk of falls.
Quality of the evidence: moderate Strength of the recommendation: strong
12. Multifactorial interventions integrating assessment with individually tailored interventions can be recommended to reduce the risk and incidence of falls among older people.
Quality of the evidence: low Strength of the recommendation: conditional
Recommendations 9–12
20 Integrated care for older people
Supporting evidence for recommendations 9–12
One systematic review of interventions designed to
reduce the incidence of falls in older people living in the
community was identified (55). The review included 159
randomized controlled trials with a total of 79 193
participants. Most trials compared a falls prevention
intervention with no intervention or one that was not
expected to reduce falls.
9: Medication review and withdrawal
Evidence is limited for the effectiveness of interventions
targeting medications (withdrawal of psychotropic
medications, for example, or educational programmes
for family physicians). Only one study showed that
withdrawal of psychotropic medication was effective in
reducing the rate of falls. Another study indicated that
educational programmes on medical review and
modification for general practitioners were effective in
reducing the numbers of falls. The quality of evidence
was low.
10: Multimodal exercise
Fifty-nine trials (13 264 participants) tested the effect of
exercise on falls in older people. Trials that combined
two or more categories of the following exercise
components were grouped as multicomponent exercise
interventions, delivered in groups or individually: gait,
balance and functional training; strength and resistance
training; flexibility; t’ai chi; general physical activity; and
endurance.
Sixteen trials (3622 participants) found evidence of
effects of multicomponent group exercise interventions
in preventing falls in older people. The quality of the
evidence was low.
Five trials (1563 participants) tested t’ai chi exercise
delivered as a group intervention. T’ai chi reduced the
rate of falls and the risk of falling. The benefit of t’ai chi
exercise on the rate of falls was greater for the subgroup
not selected for a higher risk of falling. Thus, t’ai chi
seems to be more effective in people who are not at a
high risk of falling. The overall quality of the evidence
was low.
Eight trials delivered individual exercise interventions at
the participant’s home. Home-based interventions
achieved a statistically significant reduction in the rate of
falls and the risk of falling. A trial that examined the role
of balance and strength training in daily activities
showed a statistically significant reduction in the rate of
falls. The overall quality of the evidence was moderate.
11: Home modifications
Six trials (4208 participants) investigated the
effectiveness of home safety interventions for reducing
the rate of falls and the risk of falling. The mean age of
the trial participants was over 75 years and the follow-
up period ranged from 3 to 18 months. Overall, home
safety assessment and modification interventions were
effective in reducing the rate of falls. Subgroup analysis
revealed that a home safety intervention delivered by an
occupational therapist was effective in reducing the rate
of falls in older adults who were at risk of falling
compared with delivery by a non-occupational therapist
(including nurses and trained research staff). The overall
quality was moderate.
12: Multifactorial interventions
Nineteen trials investigated the benefit of multifactorial
interventions (assessment and referral, or provision of
active interventions) in preventing falls in older people.
Multifactorial interventions that integrated assessment
with individualized intervention, usually involving a
multidisciplinary team, were effective in reducing the
rate of falls. All of the trials recruited older people living
in the community. Only one study was from a middle-
income country (Thailand); the other 18 trials were from
high-income countries, mainly Australia, Canada, China,
Denmark, Finland, the Netherlands, Taiwan, the United
Kingdom and the United States. The overall quality of
evidence was low.
Rationale for recommendations 9–12
9: Medication review and withdrawal
Low-quality evidence supports the effectiveness of
reviewing the use of psychotropic medication and of
medication withdrawal in reducing the incidence of falls
in older adults. The GDG was unclear about the harm
associated with these interventions, as no trials had
reported potential harm. Polypharmacy is acknowledged
as one of the main risk factors for falling. Medication
review should be part of any integrated care programme
addressing the risk of falls. A review of medications – in particular the withdrawal of any – requires consultation
with specialists (pharmacologists, geriatricians, mental
health care professionals). The GDG acknowledged that
21 Evidence and recommendations
the recommendation may be less feasible in low-
resource health care settings, where primary care
professionals have limited support from specialized
health care professionals. Given the low quality of the
evidence and the potential challenges of generalizing
implementation to settings where specialists are scarce,
the GDG issued a conditional recommendation.
10: Multimodal exercise
Moderate-quality evidence supported the use of
multimodal physical exercise to prevent falls. This is in
line with the physiopathology and strong association of
falls with loss of muscle mass and strength as people
age. The GDG had made a prior strong recommendation
in the guideline meeting for using multimodal exercise to
reverse declining physical capacity, and based on that
review of evidence, found very low risks associated with
the intervention. The GDG concluded that the benefits
of this recommendation outweighed any associated
harms, provided that multimodal exercise (mainly
strength and balance) training was administered by
appropriately trained professionals. The GDG identified
that interventions to prevent falls would be highly valued
by older people and that provision of exercise was
acceptable to health care providers and feasible for
implementation in the community. The GDG recognized
that resource requirements were potentially large but
that task-shifting away from professionals, and
engagement of family members could reduce the overall
costs, provided that adequate training would be
available. Given the moderate quality of the evidence,
the large potential benefits and high acceptability and
feasibility, the GDG made a strong recommendation for
multimodal exercise to prevent falls – consistent with the
previous recommendation on physical exercises to
improve mobility.
11: Home modifications
Moderate-quality evidence supports the effectiveness of
providing a home-hazard assessment and environmental
modifications for older people at risk of falls. A
combination of advice with educational interventions to
increase confidence, risk awareness and home safety is
most effective. A lengthy debate ensued regarding who
should carry out the home-hazard assessments. The
GDG recognized that, in practice, this may be by any
trained professional rather than always a health care
professional. The majority of the trials involved
assessments by trained health care professionals,
including doctors, occupational therapists, nurses,
physiotherapists, social workers and trained assessors.
The GDG acknowledged the limited specialist human
resources (occupational therapists, for example) in
low-resource settings and the associated higher costs of
delivering adequate assessments via such professionals.
The GDG recognized that, with sufficient training,
non-specialist health care professionals could perform
home-hazard assessments for at-risk older adults. Given
the moderate quality of the evidence and the potential
for task-shifting, the GDG made a strong
recommendation.
12: Multifactorial interventions
Low-quality evidence supports multifactorial
interventions targeted at the risk factors of falls as a
way to reduce their incidence in older adults living in
the community. A definite recommendation from this
evidence is difficult for the specific components.
A sensible strategy may therefore be to refer older
people for interventions that target known risk factors.
The GDG recognized that multifactorial interventions
may have resource implications for health care and for
individuals. The existing evidence base is poor for
judging the cost-effectiveness of these interventions.
However, if at-risk older adults are identified and
undergo interventions, multifactorial intervention is likely
to be cost-effective when compared with no treatment.
On this basis, and considering the low quality of the
evidence, the GDG decided to issue a conditional
recommendation.
3.3 Module III: Caregiver support Worldwide, 349 million people are estimated to be care
dependent, of whom 5%, 18 million, are children
younger than 15 years, and 29%, 101 million, are
people 60 years of age and over (57). Care dependence
arises when functional ability has fallen to a point that
the individual is no longer able without assistance to
undertake the basic tasks needed for daily living.
Coexisting chronic diseases (multimorbidity) are
frequently associated with the need for health and
social care for older people (58). Such care in most
countries is provided by informal caregivers (for
example, the care receiver’s spouse, adult children or
other relatives or friends), and women are the primary
caregivers (59). Caregivers of people with severe
declines in intrinsic capacity are at higher risk of
22 Integrated care for older people
experiencing psychological distress and depression
themselves (60). In many low- and middle-income
countries, the formal system of long-term care is poorly
developed, with the result that the negative effects of
caregiving have a profound impact on the physical,
emotional and economic status of women and other
family caregivers.
Considerations for recommendation 13
• The focus of the support intervention should be the primary family caregivers. During the initial contact,
ask the older person to identify their primary
caregiver.
• Caregiver support should be provided by appropriately trained health care professionals who
are given support and supervision relevant to their
level of involvement.
• Psychological distress and psychosocial impact on carers should be identified.
• Family caregivers experiencing stress should be offered a needs assessment and access, whether in
primary or secondary care settings, to psychosocial
support.
• Family caregivers identified with caregiving strain should be assessed for depression. Refer to the WHO
mhGAP intervention guide for information on
assessment and management of depression (45).
• The focus of a caregiver support intervention should be based on the carer’s choice, and the emphasis
should be on optimizing their well-being.
• Acknowledgement should be given to caregivers that it can be extremely frustrating and stressful to care for
people with dementia. It is nonetheless important to
help ensure that carers continue to support care-
dependent older people, avoiding hostility or neglect.
• Carers can be encouraged to respect the dignity of older people through being involved in decisions
about the person’s life as far as possible.
• Training and support can be given to caregivers for specific skills, such as managing difficult behaviour.
• If possible, practical support should be considered. Where feasible, home-based respite care is one
example, whereby another family member or other
suitable person can supervise and care for the older
person. This may relieve the main caregiver who can
then rest or carry out other activities.
• If feasible, the carer’s psychological stress could be addressed with support and problem-solving
counselling.
• Exploration can be made as to whether the person qualifies for any social benefits or other social or
financial support. This may be from government or
nongovernmental sources.
Supporting evidence for recommendation 13
Evidence on caregiver support interventions was
extracted from three systematic reviews (61–63). One of
these included 78 trials with six different interventions,
including psycho-educational interventions, supportive
interventions, psychotherapy, respite care, training of the
care recipient, and multicomponent interventions (62).
The evidence from these trials indicated that caregiver
support interventions significantly improved several
critical and important outcomes (carer burden,
depression, well-being, ability/knowledge). In particular,
psychological education for carers of older people with
mental disorders showed significant effects in reducing
caregiver strain and improving ability and knowledge.
Supportive interventions (including professional- and
peer-led groups for support and discussion) have positive
effects on the care burden. The overall quality of
evidence was moderate.
Rationale for recommendation 13
Moderate-quality evidence supports the effectiveness of
psychological intervention, support and caregiving
training for reducing caregiver strain. The significant
beneficial effects of psychological interventions on the
Psychological intervention, training and support should be offered to family members and other informal caregivers of care- dependent older people, particularly but not exclusively when the need for care is complex and extensive and/or there is significant caregiver strain.
Quality of the evidence: moderate Strength of the recommendation: strong
Recommendation 13
23 Evidence and recommendations
critical outcomes of caregiver burden and depression
were considered sufficient to warrant a
recommendation in favour of the intervention. The
balance of harms and benefits was discussed by the
GDG. No trials had identified any harm for care-
dependent older people or their caregivers that was
directly related to caregiving support interventions. The
GDG concluded that limited potential for harm was
associated with these interventions. Such interventions
are frequently very resource intensive and may require
specialist delivery. The GDG acknowledged that the
implementation of these approaches may face
challenges in community settings. In those settings
where implementation would be possible, the GDG
agreed that the interventions would be highly valued by
caregivers and would be acceptable to health care
providers. In view of equity, with the health of
caregivers frequently being ignored in the delivery of
care for older people, and coupled with the moderate
quality of the evidence, the GDG made a strong
recommendation in favour of psychological
interventions for caregivers.
25 Implementation considerations
The recommendations in these guidelines need to
be implemented using an older person-centred and
integrated approach. The rationale and evidence base for
providing older person-centred and integrated care has
been detailed in the WHO World report on ageing and
health (1). WHO describes this type of health care needed
for ageing populations as integrated care for older people
(ICOPE).
In general, ICOPE can involve integration at the policy or
sector level (macro), at the organizational or professional
level (meso), and at the clinical or intervention level
(micro) (64, 65). The approach of WHO to populations of
older people spans all these levels, but as the entry point
emphasizes integration at the level of community care.
This approach is person-centred and grounded in the
perspective that older people are more than the vessels of
their disorders or health conditions – they are individuals with unique experiences, needs and preferences. ICOPE
also encompasses the context of individuals’ daily lives,
both in terms of the people close to them and those who
are in their lives as part of a community.
Important elements for designing ICOPE for people with
chronic and multiple conditions include community-based
interventions and (66):
• comprehensive assessment and care plans shared with all providers;
• common treatment/care goals;
• strong referral and monitoring;
• community engagement and caregiver support. These ICOPE guidelines are aligned with the wider WHO
framework on strengthening integrated people-centred
health services (20), which was adopted in 2016 by the
69th session of the World Health Assembly (67).
The five steps needed to deliver the ICOPE
recommendations in an integrated manner are outlined in
Fig. 2.
Comprehensive assessments and care plans Effective interventions start with a comprehensive
assessment of the intrinsic capacity of the older person,
and the associated conditions, impairments, behaviours
and risks that may influence future capacity, and of the
person’s environment. These assessments include not
only a traditional history-taking and, if appropriate, a
physical examination, but also a thorough analysis of
the person’s values, priorities and preferences
concerning the course of their health and its
management. Comprehensive assessments and care
plans should promote the identification of underlying
conditions associated with impairments such as
hypertension, diabetes and dementia, and establish
pathways for referral and treatment.
This assessment is essential to the development of a
care plan and to tailoring interventions that are
acceptable and appropriate for the older person.
Comprehensive assessments and care plans unite
different providers around one goal: to maintain
intrinsic capacity and functional ability. They can ensure
that the necessary follow-up occurs and that links are
made between health care and social care.
The ICOPE implementation guide to accompany the
present document is focused on this process for
developing an older person’s comprehensive
assessment and care plan.
Shared decision-making and goal- setting
Integration of care can be achieved only if services and
providers are working towards the single goal of
maintaining intrinsic capacity and functional ability. It is essential that the older person is involved with
decision-making and goal-setting from the outset, and
that goals are set in accordance with the person’s
needs and preferences.
Implementation considerations4
26 Integrated care for older people
Fig. 2: Delivering ICOPE in an integrated way
Strong referral, monitoring and support Regular and sustained follow-up of older people, with
integration among different levels of care, is essential for
implementing the interventions recommended in these
guidelines. Such an approach promotes early detection
of complications or of changes in functional status, thus
preventing unnecessary emergencies and related
inefficiencies. It also provides for a forum for monitoring
progress against the care plan, as well as a means for
arranging additional support as needed. Follow-up and
support might be especially important following major
changes in the disease status, treatment plan or social
role/situation (a change in residence, for example, or the
death of a partner).
Community engagement and caregiver support
Caregiving can be demanding, and caregivers of people
with severely declining capacity are often isolated and at
high risk of experiencing psychological distress and
depression. In addition to these guidelines’
recommendations to support caregivers, caregivers also
need basic information about the older person’s health
conditions, and encouragement to develop a range of
practical skills, such as how to transfer a person from a
chair to a bed safely or how to help with bathing. The
older person and/or caregiver should be provided with
information about the community-based resources
Ensure a strong referral pathway and monitoring of the care plan
Engage communities and support caregivers
Assess older person’s needs and declining
physical and mental capacities
Implement the care plan using
principles of self-management
support
Define the goal of care and develop a
care plan with multicomponent
interventions
27 Implementation considerations
available to them. Opportunities to involve communities
and neighbourhoods more directly in supporting care
must be explored, particularly by encouraging local
volunteering and enabling older community members to
add contributions. The associations and groups that
draw together older people are one mechanism by
which such activities could happen.
The recommendations of these guidelines should be
adapted into a locally appropriate document that can
meet the needs of each country and its health services.
The headquarters of WHO will work closely with its
regional and country offices, as well as WHO
implementing partners, to ensure the communication
and country-specific adaptation of these guidelines,
through regional and national meetings.
As countries consider how to implement these
guidelines, an analysis should be made of the budgetary
and human resource requirements, and of other health
system implications, to identify which inputs and
systems are available and which areas require additional
investment. Extra input may be needed for the training
of health workers, the use of medical products and
technologies, or with regard to adaptations to health
information systems to collect data on intrinsic capacity
and functional ability.
An enabling environment should be created for
following these recommendations, including through
support to health care practitioners in the use of
evidence-based practices. In this process, the role of
local professional societies is important, and an all-
inclusive and participatory process should be
encouraged.
The inclusion of ageing and health into national policies
and plans should be considered. Creating and
strengthening linkages with other health and non-health
programmes towards achieving broader goals can
greatly enhance sustainability and effectiveness.
To further support country implementation, WHO is
producing a series of subsidiary tools to address the
clinical and service-delivery aspects of implementing the
recommendations of these ICOPE guidelines.
29 Publication, dissemination and evaluation
5.1 Publication and dissemination These guidelines are to be disseminated as a print
publication and electronically at a dedicated section of
the WHO website (http://www.who.int/ageing/health-
systems/icope). The information here is organized in line
with the priorities of the WHO Global strategy and
action plan on ageing and health (6). All of the evidence
profiles are available online, giving detailed information
about the available evidence, the GRADE (Grading of
Recommendations Assessment, Development and
Evaluation) quality analyses, the narrative descriptions of
the evidence that was not included in the GRADE
tables, and the considerations of values, preferences
and feasibility.
A series of subsidiary products deriving from these
ICOPE guidelines support the implementation of
module I (declining physical and mental capacities),
module II (geriatric syndromes) and module III (caregiver
support). These products include:
• The ICOPE implementation guide for integrated clinical care for older people, with:
� steps on how to set person-centred care goals, develop an integrated care plan, and provide
self-management support; and
� a set of colour-coded algorithms to lead the practitioner through an integrated process of
assessing, classifying and managing declining
physical and mental capacities in older age;
• A country toolkit comprising guidance for implementing and evaluating integrated health and
social care services for older people in communities;
• ICOPE mobile phone technology for health workers and older people (the WHO mAgeing initiative).
The guidelines and products are developed in English to
be translated into other WHO official languages for wider
dissemination in collaboration with WHO regional offices.
Dissemination will be supported by the publication of
selected systematic reviews and evidence in peer-
reviewed journals, and presentations and workshops at
key conferences and events.
These ICOPE guidelines and products are key tools to
support the implementation of the Global strategy and
action plan on ageing and health; activities for
disseminating them were included in the strategy’s
action plan approved by the World Health Assembly in
2016 (19). Actions include the piloting and evaluation of
these guidelines in 20 countries by 2020.
5.2 Monitoring and evaluation Implementation of these recommendations will be
monitored at the community and health-facility levels.
Data will be collected through surveys or updated lists of
service availability. Special studies can be considered
where routine monitoring is not feasible or appropriate.
A monitoring and evaluation framework, including a list
of core indicators, is to be developed and included in the
ICOPE country toolkit. Indicators will measure the
performance of service delivery (the health system
inputs, and the processes and outputs of service
delivery), as well as the feasibility and acceptability of the
recommendations. An international working group of
experts, including representatives of the WHO regions
and countries, will develop the framework and oversee
monitoring and evaluation activities. Broader stakeholder
engagement in policy design, implementation, and
monitoring and evaluation will help to ensure that the
national adaptation of these guidelines results in
programmes that are legitimate, acceptable, effective,
equitable, and address community needs.
Intermediate health systems outcomes and the impacts
of the interventions will be measured by the WHO global
survey on Healthy Ageing, which was also included in
the WHO Global strategy and action plan on ageing and
health approved by the World Health Assembly (6). The
global survey will provide information at a country level
Publication, dissemination and evaluation 5
30 Integrated care for older people
on health status, health needs, and how well needs are
being met. This information will form the basis for
international comparisons and a baseline against which
to measure the impact of the programme.
The WHO Department of Ageing and Life Course will
work closely with the Health Data Collaborative1 to
ensure harmonization of standards and tools and
alignment with the WHO 2015 global reference list of
100 core health indicators (68).
5.3 Future review and update The WHO Department of Ageing and Life Course will
regularly monitor new evidence in priority areas, with
the assistance of WHO collaborating centres. The
department will also collect regular feedback from
country implementation teams on ICOPE products.
These ICOPE guidelines will be updated after a four-year
period, applying a similarly rigorous methodology. WHO
welcomes suggestions for any additional issues that
should be considered for inclusion in future guidelines.
Please email these to Dr Islene Araujo de Carvalho:
araujodecarvalho@who.int.
1 Further information is availabe at http://www.healthdatacollaborative.org
31 References
1. World report on ageing and health. Geneva: World Health Organization (WHO); 2015 (http://www.who.int/ageing/ publications/world-report-2015, accessed 4 July 2017).
2. United Nations, Department of Economic and Social Affairs, Population Division. World population ageing 2015. New York (NY): United Nations (ST/ESA/SER.A/390; http://www.un.org/en/development/desa/population/ publications/pdf/ageing/WPA2015_Report.pdf, accessed 11 September 2017).
3. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. doi:10.1016/S0140-6736(12)62167-9.
4. Daniels R, van Rossum E, de Witte L, Kempen GI, van den Heuvel W. Interventions to prevent disability in frail community-dwelling elderly: a systematic review. BMC Health Serv Res. 2008;8:278. doi:10.1186/1472-6963-8-278.
5. Daniels R, van Rossum E, Metzelthin S, Sipers W, Habets H, Hobma S, et al. A disability prevention programme for community-dwelling frail older persons. Clin Rehabil. 2011;25(11):963–74. doi:10.1177/0269215511410728.
6. Global strategy and action plan on ageing and health. In: WHO [website]. Geneva: WHO; 2017 (http://who.int/ ageing/global-strategy, accessed 5 July 2017).
7. Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel J-P, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54. doi:10.1016/S0140-6736(15)00516-4.
8. Jotheeswaran AT, Bryce R, Prina M, Acosta D, Ferri CP, Guerra M, et al. Frailty and the prediction of dependence and mortality in low- and middle-income countries: a 10/66 population-based cohort study. BMC Med. 2015;13:138. doi:10.1186/s12916-015-0378-4.
9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23. doi:10.1093/ageing/afq034.
10. Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr., Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990): 266–73. doi:10.1016/S0140-6736(14)62000-6.
11. Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and
total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51(5):636–41. doi:10.1034/j.1600-0579.2003.00207.x.
12. Kaiser MJ, Bauer JM, Ramsch C, Uter W, Guigoz Y, Cederholm T, et al. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13(9):782–8.
13. Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):367–73. doi:10.2471/BLT.13.128728.
14. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–8. doi:10.1136/bjophthalmol-2011-300539.
15. Prince M, Jackson J, editors. World Alzheimer Report 2009. London: Alzheimer’s Disease International; 2009 (http://www.alz.co.uk/research/files/ WorldAlzheimerReport.pdf, accessed 8 August 2017).
16. Mavrodaris A, Powell J, Thorogood M. Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review. Bull World Health Organ. 2013;91:773–83. doi:10.2471/BLT.13.118422.
17. Preventing suicide: a global imperative (executive summary). Geneva: WHO, 2014:WHO/MSD/MER/14.2 (http://www.who.int/mental_health/suicide-prevention/ exe_summary_english.pdf, accessed 9 August 2017).
18. Meeks TW, Vahia IV, Lavretsky H, Kulkarni G, Jeste DV. A tune in “a minor” can “b major”: a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord. 2011;129(1–3):126–42. doi:10.1016/j.jad.2010.09.015.
19. Sixty-ninth World Health Assembly agenda item 13.4. The global strategy and action plan on ageing and health 2016–2020: towards a world in which everyone can live a long and healthy life. Geneva: WHO; 2016 (WHA69.3; http://apps.who.int/gb/ebwha/pdf_files/ WHA69/A69_R3-en.pdf, accessed 12 September 2017).
20. WHO framework on integrated people-centred health services. In: WHO [website]. Geneva: WHO; 2017 (http:// www.who.int/servicedeliverysafety/areas/people-centred- care, accessed 6 July 2017).
References
32 Integrated care for older people
21. Lehmann U, Sanders D. Community health workers: what do we know about them? The state of the evidence on programmes, activities, costs and impact on health outcomes of using community health workers. Geneva: WHO; 2007 (http://www.who.int/hrh/documents/ community_health_workers.pdf, accessed 11 September 2017).
22. WHO handbook for guideline development – 2nd ed. Geneva: WHO; 2011 (http://www.who.int/publications/ guidelines/handbook_2nd_ed.pdf, accessed 30 June 2017).
23. Cochrane PICO ontology. In: Cochrane linked data [website]. London: The Cochrane Collaboration; 2017 (http://linkeddata.cochrane.org/pico-ontology, accessed 30 June 2017).
24. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. doi:10.1016/j.jclinepi.2010.04.026.
25. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–42. doi:10.1503/cmaj.090449.
26. Mitra S, Sambamoorthi U. Disability prevalence among adults: estimates for 54 countries and progress toward a global estimate. Disabil Rehabil. 2014;36(11):940–7. doi:10.3109/09638288.2013.825333.
27. Global recommendations on physical activity for health. Geneva: WHO; 2010 (http://www.who.int/ dietphysicalactivity/factsheet_recommendations, accessed 11 July 2017).
28. Bauer JM, Kaiser MJ, Anthony P, Guigoz Y, Sieber CC. The Mini Nutritional Assessment – its history, today’s practice, and future perspectives. Nutr Clin Pract. 2008;23(4):388–96. doi:10.1177/0884533608321132.
29. Kabir ZN, Ferdous T, Cederholm T, Khanam MA, Streatfied K, Wahlin A. Mini nutritional assessment of rural elderly people in bangladesh: the impact of demographic, socio-economic and health factors. Public Health Nutr. 2006;9(8):968-74. doi:10.1017/PHN2006990.
30. Baldwin C, Weekes CE. Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults. Cochrane Database Syst Rev. 2011;(9):CD002008.
31. Milne AC, Potter J, Vivanti A, Avenell A. Protein and energy supplementation in elderly people at risk from malnutrition. Cochrane Database Syst Rev. 2009;(2):CD003288.
32. Munk T, Tolstrup U, Beck AM, Holst M, Rasmussen HH, Hovhannisyan K, Thomsen T. Individualised dietary counselling for nutritionally at-risk older patients following discharge from acute hospital to home: a systematic review and meta-analysis. J Hum Nutr Diet. 2016;29(2):196–208. doi:10.1111/jhn.12307.
33. Prevention of blindness from diabetes mellitus: report of a WHO consultation held in Geneva, 9-11 November 2005.
Geneva: WHO; 2006 (http://www.who.int/blindness/ Prevention%20of%20Blindness%20from%20Diabetes%20 Mellitus-with-cover-small.pdf, accessed 11 July 2017).
34. Prevention of blindness and visual impairment: priority eye diseases: refractive errors and low vision. In: World Health Organization [website]. Geneva: WHO; 2017 (http://www. who.int/blindness/causes/priority/en/index4.html, accessed 30 June 2017).
35. Smeeth L, Iliffe S. Community screening for visual impairment in the elderly. Cochrane Database Syst Rev. 2006;(3):CD001054.
36. Coleman AL, Yu F, Keeler E, Mangione CM. Treatment of uncorrected refractive error improves vision-specific quality of life. J Am Geriatr Soc. 2006;54(6):883–90. doi:10.1111/j.1532-5415.2006.00817.x.
37. Owsley C, McGwin G, Jr., Scilley K, Meek GC, Seker D, Dyer A. Effect of refractive error correction on health- related quality of life and depression in older nursing home residents. Arch Ophthalmol. 2007;125(11):1471–7. doi:10.1001/archopht.125.11.1471.
38. Foss AJE, Harwood RH, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following second eye cataract surgery: a randomised controlled trial. Age Ageing. 2006;35(1):66–71. doi:10.1093/ageing/afj005.
39. Harwood RH, Foss AJE, Osborn F, Gregson RM, Zaman A, Masud T. Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial. Br J Ophthalmol. 2005;89(1):53–9. doi:10.1136/bjo.2004.049478.
40. Laidlaw DAH, Harrad RA, Hopper CD, Whitaker A, Donovan JL, Brookes ST, et al. Randomised trial of effectiveness of second eye cataract surgery. Lancet. 1998;352(9132):925–9. doi:10.1016/S0140-6736(97)12536-3.
41. Guidelines for hearing aids and services for developing countries, second edition. Geneva: WHO; 2004 (http:// www.who.int/pbd/deafness/en/hearing_aid_guide_en.pdf, accessed 11 July 2017).
42. Mulrow CD, Aguilar C, Endicott JE, Tuley MR, Velez R, Charlip WS, et al. Quality-of-life changes and hearing impairment: a randomized trial. Ann Intern Med. 1990;113(3):188–94. doi:10.7326/0003-4819-113-3-188.
43. Yueh B, Souza PE, McDowell JA, Collins MP, Loovis CF, Hedrick SC, et al. Randomized trial of amplification strategies. Arch Otolaryngol Head Neck Surg. 2001;127(10):1197–204. doi:10.1001/archotol.127.10.1197.
44. Kurz AF, Leucht S, Lautenschlager NT. The clinical significance of cognition-focused interventions for cognitively impaired older adults: a systematic review of randomized controlled trials. Int Psychogeriatr. 2011;23(9):1364–75. doi:10.1017/S1041610211001001.
45. mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0. Geneva: WHO; 2016 (http://www.
33 References
who.int/mental_health/mhgap/mhGAP_intervention_ guide_02, accessed 19 September 2017).
46. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58(3):249–65.
47. Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PLoS One. 2014;9(6):e100100. doi:10.1371/journal.pone.0100100.
48. van Zoonen K, Buntrock C, Ebert DD, Smit F, Reynolds CF, 3rd, Beekman ATF, et al. Preventing the onset of major depressive disorder: a meta-analytic review of psychological interventions. Int J Epidemiol. 2014;43(2):318–29. doi:10.1093/ije/dyt175.
49. Prince M, Acosta D, Ferri CP, Guerra M, Huang Y, Jacob K, et al. The association between common physical impairments and dementia in low and middle income countries, and, among people with dementia, their association with cognitive function and disability. A 10/66 Dementia Research Group population-based study. Int J Geriatr Psychiatry. 2011;26(5):511–9. doi:10.1002/ gps.2558.
50. Regional Office for the Western Pacific. Ageing and Health: a health promotion approach for developing countries. Manila: WHO; 2003 (http://www.wpro.who.int/ publications/docs/Ageing_and_Health.pdf, accessed 14 July 2017).
51. Smith AL, Wang P-C, Anger JT, Mangione CM, Trejo L, Rodriguez LV, et al. Correlates of urinary incontinence in community-dwelling older Latinos. J Am Geriatr Soc. 2010;58(6):1170–6. doi:10.1111/j.1532-5415.2010.02814.x.
52. Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2000(2):CD002113.
53. Dumoulin C, Hay-Smith J, Habée-Séguin GM, Mercier J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women: a short version Cochrane systematic review with meta- analysis. Neurourol Urodyn. 2015;34(4):300–8. doi:10.1002/nau.22700.
54. Soriano TA, DeCherrie LV, Thomas DC. Falls in the community-dwelling older adult: a review for primary-care providers. Clin Interv Aging. 2007;2(4):545–53. doi:10.2147/CIA.S1080.
55. Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012;(9):CD007146.
56. WHO global report on falls prevention in older age. Geneva: WHO; 2007 (http://www.who.int/ageing/ publications/Falls_prevention7March.pdf, accessed 4 August 2017).
57. Current and future long-term care needs. Geneva: WHO; 2002 (http://www.who.int/chp/knowledge/publications/ ltc_needs.pdf, accessed 11 September 2017).
58. Fortin M, Soubhi H, Hudon C, Bayliss EA, van den Akker M. Multimorbidity’s many challenges. BMJ. 2007;334(7602):1016–7. doi:10.1136/bmj.39201.463819.2C.
59. Alzheimer’s Disease International, WHO. Supporting informal caregivers of people living with dementia. Thematic brief for the first WHO Ministerial Conference on Global Action Against Dementia, 16–17 March 2015. Geneva: WHO; 2015 (http://www.who.int/mental_health/neurology/dementia/ dementia_thematicbrief_informal_care.pdf, accessed 11 September 2017).
60. Douglas SL, Daly BJ, Kelley CG, O’Toole E, Montenegro H. Impact of a disease management program upon caregivers of chronically critically ill patients. Chest. 2005;128(6):3925–36. doi:10.1378/chest.128.6.3925.
61. Shaw C, McNamara R, Abrams K, Cannings-John R, Hood K, Longo M, et al. Systematic review of respite care in the frail elderly. Health Technol Assess. 2009;13(20):1–224, iii. doi:10.3310/hta13200.
62. Sorensen S, Pinquart M, Duberstein P. How effective are interventions with caregivers? An updated meta-analysis. Gerontologist. 2002;42(3):356–72. doi:10.1093/geront/42.3.356.
63. Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, Drummond M. The effectiveness and cost- effectiveness of respite for caregivers of frail older people. J Am Geriatr Soc. 2007;55(2):290–9. doi:10.1111/j.1532-5415.2006.01037.x.
64. Valentijn PP, Schepman SM, Opheij W, Bruijnzeels MA. Understanding integrated care: a comprehensive conceptual framework based on the integrative functions of primary care. Int J Integr Care. 2013;13:e010. doi:10.5334/ijic.886.
65. Curry N, Ham C. Clinical and service integration: the route to improved outcomes. London: The King’s Fund; 2010 (http://www.kingsfund.org.uk/sites/default/files/Clinical- and-service-integration-Natasha-Curry-Chris-Ham-22- November-2010.pdf, accessed 8 August 2017).
66. Goodwin N, Sonola L, Thiel V, Kodner DL. Co-ordinated care for people with complex chronic conditions. London: The King’s Fund; 2013 (http://www.kingsfund.org.uk/sites/ default/files/field/field_publication_file/co-ordinated-care- for-people-with-complex-chronic-conditions-kingsfund- oct13.pdf, accessed 11 September 2017).
67. Sixty-ninth World Health Assembly agenda item 16.1: Strengthening integrated, people-centred health services. Geneva: WHO; 2016 (WHA69.24; http://apps.who.int/iris/ bitstream/10665/252804/1/A69_R24-en.pdf, accessed 11 September 2017).
68. 2015 global reference list of 100 core health indicators. Geneva: WHO; 2015 (http://apps.who.int/iris/ bitstream/10665/173589/1/WHO_HIS_HSI_2015.3_eng.
pdf, accessed 11 September 2017).
34 Integrated care for older people
Emiliano Albanese, World Health Organization (WHO) Collaborating Centre, University of Geneva, Geneva,
Switzerland.
Olivier Bruyère, Department of Public Health, Epidemiology and Health Economics, University of Liège,
Liège, Belgium.
Matteo Cesari, Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Alan Dangour, London School of Hygiene & Tropical Medicine, London, United Kingdom of Great
Britain and Northern Ireland.
Amit Dias, Department of Preventive and Social Medicine, Goa Medical College Bambolim, Goa, India.
Astrid Fletcher, Department of Epidemiology and Population Health, London School of Hygiene & Tropical
Medicine, London, United Kingdom.
Dorothy Forbes, Faculty of Nursing, University of Alberta, Edmonton Clinic Health Academy, Edmonton,
Alberta, Canada.
Anne Forster, Stroke Rehabilitation, Academic Unit of Elderly Care and Rehabilitation, University of Leeds,
Leeds, United Kingdom.
Mariella Guerra, Institute of Memory, Depression and Related Disorders, Lima, Peru.
Jill Keeffe, L.V. Prasad Eye Institute, WHO Collaborating Centre for Prevention of Blindness, Hyderabad, India.
Ngaire Kerse, School of Population Health Faculty of Medical and Health Sciences, University of Auckland,
Auckland, New Zealand.
Qurat ul Ain Khan, Department of Psychiatry, Aga Khan University Hospital, Karachi, Pakistan.
Chiung-ju Liu, Department of Occupational Therapy, School of Health and Rehabilitation Sciences, Indiana
University, Indianapolis, Indiana, United States of
America.
Gudlavalleti V.S. Murthy, Indian Institute of Public Health, Hyderabad, Madhapur, India.
Serah Nyambura Ndegwa, University of Nairobi, Nairobi, Kenya.
Joseph G. Ouslander, Department of Integrated Medical Sciences, Charles E. Schmidt College of
Medicine, Florida Atlantic University, Boca Raton, Florida,
United States.
Martin Prince (GDG chair), Institute of Psychiatry, Psychology and Neuroscience, King’s College London,
United Kingdom.
Jean-Yves Reginster, Department of Public Health, Epidemiology and Health Economics, University of Liège,
Liège, Belgium.
Luis Miguel F. Gutiérrez Robledo, Instituto Nacional de Geriatría, Institutos Nacionales de Salud de México,
Mexico City, Mexico.
John F Schnelle, Center for Quality Aging Geriatric Research, Education and Clinical Center, Vanderbilt
University Medical Center, Nashville, Tennessee, United
States.
Kelly Tremblay, University of Washington, Seattle, Washington, United States.
Jean Woo, Department of Medicine and Therapeutics, and Institute of Aging, The Chinese University of Hong
Kong, Hong Kong, China.
Annex 1: Guideline development group (GDG) members
35 Annex 2
Individuals involved in the assessment of conflicts of
interest:
– John Beard, Director, Department of Ageing and Life Course, WHO headquarters
– Islene Araujo De Carvalho, Senior Policy and Strategy Adviser, Department of Ageing and Life
Course, WHO headquarters
– Nandi Siegfried, Independent Consultant, Guideline Methodologist
– Jotheeswaran Amuthavalli Thiyagarajan, Technical Officer, Department of Ageing and Life Course,
WHO headquarters
– Martin Prince (guideline development group [GDG] chair), Professor of Epidemiological Psychiatry,
Health Services and Population Research Institute
of Psychiatry, King’s College London, London,
United Kingdom of Great Britain and Northern
Ireland.
The minutes presented below summarize the
discussions with the ICOPE GDG chair and the director
of the Department of Ageing and Life Course on the
management of declarations of interest for GDG
members and external resource people for the GDG
meeting held at WHO headquarters in Geneva. The
follow-up and suggested actions agreed on to
manage the conflicts of interest declared are
summarized below:
I. WHO is under scrutiny on the management of
known and perceived conflicts of interest. The
revised declaration-of-interest policy for experts2
and the framework of engagement with non-state
actors3 are followed.
II. Conflicts of interest are a subjective matter and it
is very important that not only the known but also
the perceived conflicts of interest are declared and
managed appropriately, particularly for guideline
development at WHO.
III. The declarations are shared only with the WHO
steering group for guideline development and only
summaries of the declarations are available to
meeting participants.
IV. Specific cases in which potential conflicts of
interest have been declared will be discussed and
the agreements and follow up actions summarized
below.
V. Participants of the GDG meetings participate in
their individual capacities and not as institutional
representatives.
VI. The WHO Secretariat and external resource people
do participate in deliberations leading to decision-
making (voting). They do not participate in any of
the closed sessions.
A. Members and contributors with no relevant interests declared on the declaration-of-interest form and no relevant interests found in the CV/ résumé:
– Martin Prince, GDG chair, Professor of Epidemiological Psychiatry, Health Services and
Population Research Institute of Psychiatry, King’s
College London, London, United Kingdom
– Emiliano Albanese, Head, Division of Public Mental Health, and Aging, Institute of Global Health,
Geneva, Switzerland
– Olivier Bruyère, Department of Public Health, Epidemiology and Health Economics, University of
Liège, Liège, Belgium
– Kralj Carolina, King’s College London, London, United Kingdom
Annex 2: Assessment of conflicts of interest
2 Available at http://www.who.int/occupational_health/ declaration_of_interest.pdf
3 Available at http://www.who.int/about/collaborations/ non-state-actors
36 Integrated care for older people
– A.B. Dey, Professor and Head of Department, Department of Geriatric Medicine, All India Institute
of Medical Science, New Delhi, India
– Amit Dias, Department of Preventive and Social Medicine, Goa Medical College Bambolim, Goa,
India
– Meredith Fendt-Newlin, Social Care Workforce Research Unit, King’s College London, London,
United Kingdom
– Astrid Fletcher, Faculty of Epidemiology and Population Health, London School of Hygiene &
Tropical Medicine, London, United Kingdom
– Dorothy Forbes, Faculty of Nursing, University of Alberta, Edmonton Clinic Health Academy, Alberta,
Canada
– Anne Foster, Professor of Stroke Rehabilitation, Faculty of Medicine and Health, Leeds Institute of
Health Sciences, University of Leeds, Leeds, United
Kingdom
– Mariella Guerra, Institute of Memory, Depression and Related Disorders, Lima, Peru
– Jill Keeffe, L.V. Prasad Eye Institute, WHO Collaborating Centre for Prevention of Blindness,
Hyderabad, India
– Qurat Khan, Assistant Professor, Department of Psychiatry, Aga Khan University Hospital, Karachi,
Pakistan
– Gudlavalleti V.S. Murthy, Indian Institute of Public Health, Hyderabad, Madhapur, India
– Joseph G. Ouslander, Chair, Department of Integrated Medical Science, and Senior Associated
Dean of Geriatric Programs, Charles E. Schmidt
College of Medicine, Florida Atlantic University,
Boca Raton, Florida, United States of America
– Minha Rajput-Ray, Medical Director, Need for Nutrition Education/Innovation Programme, Global
Centre for Nutrition and Health, Cambridge, United
Kingdom
– Sumantra Ray, Lead Clinician (National Diet and Nutrition Survey), Medical Research Council (Human
Nutrition Research), Cambridge, United Kingdom
– Luis Miguel F. Gutiérrez Robledo, Director-General, Instituto Nacional de Geriatría Institutos Nacionales
de Salud de México, Mexico City, Mexico
– John F. Schnelle, Professor of Medicine, Director, Center for Quality Aging Geriatric Research,
Education and Clinical Center, Vanderbilt Center for
Quality Aging, Nashville, Tennessee, United States
– Alessandra Stella, Independent consultant, Rome, Italy
– Richard Uwakwe, Faculty of Medicine Nnamdi Aikiwe University Nnewi Campus, Awka, Nigeria
– Abebaw Fekadu Wassie, Associate Professor, Addis Ababa University, College of Health Science,
Department of Psychiatry, Addis Ababa, Ethiopia
– Jean Woo, Department of Medicine and Therapeutics, and Institute of Aging, The Chinese University of Hong
Kong, Hong Kong, China
B. Guideline development group members who have declared an interest on the declaration-of- interest form or for whom a potentially relevant interest has been noted from the CV/résumé:
1. Olivier Bruyère, Department of Public Health,
Epidemiology and Health Economics, University of
Liège, Liège, Belgium
Professor Bruyère did not declare any interests on the
declaration-of-interest form. It is noted from his CV
that he is a member of the Scientific Advisory Board of
the European Society for Clinical and Economic Aspects
of Osteoporosis, Osteoarthritis and Musculoskeletal
Diseases (ESCEO).
ESCEO is a not-for-profit organization, dedicated to a
close interaction between clinical scientists dealing with
bone, joint and muscle disorders, the pharmaceutical
industry developing new compounds in this field,
regulators responsible for the registration of such
medications, and health policy-makers, to integrate the
management of osteoporosis and osteoarthritis within
the comprehensive perspective of health resources
utilization.
The objective of ESCEO is to provide practitioners with
the latest clinical and economic information, allowing
them to organize their daily practice, using an
evidence-based-medicine perspective, with a cost-
conscious perception. Financial details can be found in
the organization’s annual report.44 Available at http://www.esceo.org/reports
37 Annex 2
Action: It was felt that this interest was insignificant or
minimal and unlikely to affect, or be reasonably
perceived to affect, Professor Bruyère’s judgement in
the development of the present guidelines. No further
action was necessary.
2. Alan Dangour, London School of Hygiene & Tropical
Medicine, London, United Kingdom
Dr Dangour declared in the declaration-of-interest
form that he had received from the United Kingdom
Department of Health a competitive grant (£660 000)
to conduct research on nutrition in older people. He
also provided expert opinion to the same department
for a judicial review on nutrition in older people.
Action – Participation with verbal disclosure: It was
felt that this interest was relatively minor and Dr
Dangour should continue his involvement in the GDG.
At the start of the meeting, he was requested to
verbally disclose the research involvement to all
meeting participants.
3. Jean-Yves Reginster, Department of Public Health
Sciences, University of Liège, Liège, Belgium
Professor Reginster declared that he was president of
the European Society for Clinical and Economic
Aspects of Osteoporosis, Osteoarthritis and
Musculoskeletal Diseases (ESCEO). ESCEO is a not-for-
profit organization, dedicated to a close interaction
between clinical scientists dealing with bone, joint and
muscle disorders, pharmaceutical industry developing
new compounds in this field, regulators responsible
for the registration of such medications and health
policy-makers, to integrate the management of
osteoporosis and osteoarthritis within the
comprehensive perspective of health resources
utilization. The objective of ESCEO is to provide
practitioners with the latest clinical and economic
information, allowing them to organize their daily
practice, using an evidence-based-medicine
perspective, with a cost-conscious perception.
Financial details can be found in the organization’s
annual report.5
Action – Partial exclusion: It was decided that
Professor Reginster could continue as a member of
the GDG and participate in the deliberations of the
evidence to inform all of the guidelines. He will be
excluded from participating in the decision-making
(voting) process relating to drafting the final
recommendation on nutritional supplements for lean
muscle mass and muscle strength. At the start of the
meeting, Professor Reginster was asked to disclose
verbally his position in ESCEO, his intellectual interests
and the interests of his organization in the guidelines
related to nutritional interventions targeting muscle
strength and lean muscle mass.
4. Matteo Cesari, Gérontopôle, Centre Hospitalier
Universitaire de Toulouse, Toulouse, France
Professor Cesari declared that he was a speaker for Nestlé. Nestlé is a leading company that manufactures
nutritional supplements for older people, targeting
their unique nutritional needs. A small number of the
trials included in the reviews had been funded by
Nestlé or tested the benefit of Nestlé nutritional
supplements for older people.
Action – Partial exclusion: It was decided that
Professor Cesari could continue as a member of the
GDG and participate in the deliberations of the
evidence to inform all guidelines. He was excluded
from participating in the decision-making (voting)
process relating to the drafting of the final
recommendation on oral nutritional supplementation
for older people with undernutrition.
C. External resource people with no relevant interests declared on the declaration-of-interest form or for whom such interests declared are insignificant or minimal
1. Nandi Siegfried, Consultant, Guideline Methodologist,
Independent Consultant
Dr Siegfried did not declare any interests on the
declaration-of-interest form. It was noted from her
CV/résumé that she has provided technical support,
expert input, and facilitation to WHO clinical
guidelines development processes in the fields of HIV/
AIDS and nutrition.
Action: Dr Siegfried was a technical resource and did
not therefore participate in any of the closed sessions
(voting on or drafting of final recommendations).
5 Available at http://www.esceo.org/reports
38 Integrated care for older people
1. Mobility loss
Does physical exercise training (progressive resistance training or multimodal exercise) produce any benefit or harm for older people with limitations in activities of daily living (ADLs)?
Population
• Non-institutionalized older people with limitations in ADLs
Intervention
• Progressive resistance training • Physical exercise (balance training or
multicomponent)
• Physical rehabilitation (tailored to older person’s need)
Comparison
• No intervention • Control (low physical activity or any social or other
intervention)
• Usual care activities
Outcomes
• Main function measure (higher score = better function)
• Physical function domain of Short Form Health Survey (SF-36/SF-12)
• ADLs measure • Activity level measure • Main lower limb strength measure • Main measure of aerobic function • Six-minute walk test (metres) • Balance measures (higher = better balance) • Gait speed (metres/second) • Timed walk (seconds) • Timed “up-and-go” (seconds) • Time taken to stand from seated in a chair • Stair climbing (seconds) • Chair stand within time limit (number of times) • Vitality (SF-36/Vitality plus scale, higher = more
vitality)
• Pain (higher score = less pain, bodily pain on SF-36) • Pain (lower score = less pain) • Mortality • Adverse effect
2. Undernutrition Does oral nutritional supplement, dietary advice or mealtime enhancement produce any benefit for older people at risk of undernutrition or who are affected by undernutrition?
Population
• Older people, 60 years of age and over (both male and female) at risk of undernutrition
• Older people, 60 years of age and over (both male and female) affected by undernutrition
Intervention
• Oral nutrition supplement (macro- and/or micronutrients)
• Dietary advice • Mealtime strategy to improve food intake
Comparison
• Placebo • Usual care • Control group (waiting to receive intervention)
Outcomes
• Critical: mortality, weight change • Important: hand grip strength, ADLs
Setting
• Primary health care/community
3. Vision impairment For older people with vision impairment, does case finding, provision of care or referral produce any benefit and/or harm compared with controls?
Annex 3: Scoping questions
39 Annex 3
Population
• Older people 60 years of age and over (both male and female) with refractive errors or cataract
Intervention
• Case-finding and referral for refractive error or cataract
• Case-finding and immediate provision of care for refractive error
Comparison
• Usual care
Outcomes
• Critical: visual acuity, vision-related quality of life, self-reported improvement
• Important: social function, depression
Setting
• Primary health care/community
4. Hearing loss Does case-finding and provision of hearing aids or assistive listening devices produce any benefit or harm for older people 60 years of age and over with hearing loss?
Population
• Older people 60 years of age and over (both male and female) with hearing loss
Intervention
• Screening and provision of hearing aid or assistive listening device
• Educational intervention to improve uptake or use of hearing aid
Comparison
• Referral or no service or delayed treatment
Outcomes
• Critical: improvement in communication, social function, hearing function
• Important: depression, quality of life, use of verbal communication strategy, self-reported hearing
handicap scale
5. Cognitive impairment Does cognitive stimulation, cognitive training or rehabilitation produce any benefit for older people with cognitive impairment or early stage of dementia?
Population
• Older people 60 years of age and over (both male and female) with cognitive impairment or mild
cognitive impairment
• Older people 60 years of age and over (both male and female) with early stage of Alzheimer’s disease
and vascular dementia
Intervention
• Cognitive stimulation • Cognitive training • Cognitive rehabilitation
Comparison
• No treatment/usual care/standard treatment • Waiting list control • Active control condition
Outcomes
• Critical: cognitive functions assessment by Mini Mental State Examination (MMSE) and Alzheimer’s
Disease Assessment Scale – Cognitive subscale
(ADAS-Cog), immediate and delayed memory recall
6. Depressive symptoms Does psychological intervention (behavioural activation, cognitive behavioural therapy, psychoeducational therapy, interpersonal therapy, problem-solving therapy, stepped-care protocol therapy, or life-review therapy) produce any benefit or harm for older people with depressive symptoms?
Population
• Older people 60 years of age and over (both male and female) with depressive symptoms with or
without diagnostic status (depressive episode or
disorder)
Interventions
• Behavioural activation, cognitive behavioural therapy, psychoeducational therapy, interpersonal therapy,
problem-solving therapy, stepped-care protocol
therapy, or life-review therapy
Comparison
• Usual care or waiting list
Outcomes
• Critical: depressive symptoms, incidence of clinically significant depression (depressive episode or major
depressive episode)
40 Integrated care for older people
7. Urinary incontinence Do non-pharmacological interventions (prompted voiding, timed voiding, toilet training, habit retraining, pelvic floor muscle training) produce any benefit and/or harm for older people with urinary incontinence?
Population
• Older people with urgency or stress or mixed urinary incontinence
Intervention
• Prompted voiding • Timed voiding • Bladder training • Habit retraining • Pelvic floor muscle training
Comparison
• No intervention/usual care
Outcomes
• Critical: proportion of mean change in frequency of urinary incontinence, change in mean
proportion of hourly checks that are wet, number
of patients with reductions in incidence of daytime
incontinence, number of patients with reductions
in incidence of night-time incontinence,
incontinent episodes in 24 hours, mean urinary
incontinence incidence per 24 hours, urinary
incontinence symptoms
• Important: perceived cure, self-initiated toileting, median percentage of checks wet, number of
incontinent episodes, urinary incontinence urgency,
urinary incontinence frequency, nocturia, quality of
life
8. Risk of falls Do interventions to prevent falls produce any benefit or harm for older people (60 years of age and over) at risk of falls?
Population
• Older people 60 years of age and older (both male and female) at risk of falls
Intervention
• Multicomponent exercise programme/strength training
• Falls risk assessment by the physiotherapist to develop individualized falls and injury prevention
• Individually tailored exercises • Medication review • Withdrawal of psychotropic medication • Multifactorial interventions with comprehensive
geriatric assessment
• Environmental modification for home safety • Assistive technology (walking aid, hearing aid,
personal alarm system)
• Footwear assessment • Insertion of a pacemaker (carotid sinus
hypersensitivity)
Comparison
• Usual care or standard care • Placebo or no active intervention • Waiting list control • Active control intervention
Outcome
• Critical: rate of falls
Setting
• Primary health care/community
9. Caregiver support Does respite care or psychosocial support produce any benefit or harm for family caregivers of care-dependent older people?
Population
• Family caregivers (both male and female) of care- dependent people of 60 years of age and over
Intervention
• Respite care • Psychosocial support • Technology-based interventions
Comparison
• Usual or standard care • Waiting list control • Active control intervention
Outcomes
• Critical: caregiver burden, caregiver depression, care recipients’ symptoms
• Important: well-being, ability/knowledge, quality of life, anger, anxiety
41 Annex 4
STEP ONE
Search For the evidence synthesis, we performed a
comprehensive search for published systematic
reviews and randomized controlled trials (RCTs) using
the Cochrane Library, Embase, Ovid MEDLINE and
PsycINFO databases.6 A search strategy was developed
for each of the scoping questions (Annex 3). Details of
the search strategies can be found in the GRADE
(Grading of Recommendations Assessment,
Development and Evaluation) tables7 and evidence
profiles appended to these guidelines, which are
available at http://www.who.int/ageing/health-
systems/icope.
STEP TWO
Screening Identified references were exported to reference
manager software and duplicates were identified and
deleted. References were screened first by title and
abstract and then by full text to identify systematic
reviews and RCTs. Details of the search process and
the number of records retrieved and assessed for
eligibility are presented in a PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) flow diagram for each PICO (population,
intervention, comparison, outcome) question in the
relevant GRADE evidence profile documents.
STEP THREE
Eligibility Systematic reviews that reported the methodological
quality assessment of included RCTs were eligible for
inclusion. Of the 32 included systematic reviews, 20
were published between 2011 and 2015 and were
updated with newer RCTs identified in consultation
with guideline development group (GDG) members.
The remaining 12 systematic reviews were published
before 2011, and were updated with new RCTs
identified from the search strategies during screening.
STEP FOUR
Quality assessment of included studies The AMSTAR appraisal tool was used on each
included systematic review to provide an indication of
review conduct quality (see Fig. 3). No review was
excluded based on the cut-off points in the AMSTAR
tool as there is no score recommended for separating
high- from low-quality reviews.
STEP FIVE
Meta-analysis Where new trials were identified and included
comparable interventions and outcomes, meta-
analysis was conducted either as an update to the
analyses contained in a previous review, or as a de
novo meta-analysis. Review Manager 5 (RevMan 5)
software was used to calculate mean differences and
standardized mean differences between intervention
and control groups. Relative risks or odds ratios were
presented for categorical outcomes.
STEP SIX
GRADE assessment The meta-analysed results were exported to the
GRADE profiler software for evidence grading work.8
The evidence was graded as very low, low, moderate,
or high, based on the limitations of the included
Annex 4: Evidence process
6 See: — Cochrane Library (http://www.cochranelibrary.com/cochrane-database-of-systematic-reviews) — Embase (http://www.elsevier.com/solutions/embase-biomedical-research) — Ovid MEDLINE (http://ovid.com/site/catalog/databases/901.jsp) — PsycINFO (http://www.apa.org/pubs/databases/psycinfo/index.aspx) 7 Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al. GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. doi:10.1016/j.jclinepi.2010.04.026. 8 GRADE’s software for summary of findings tables, health technology assessment and guidelines [website]. Hamilton (ON): McMaster University and Evidence Prime; 2015 (http://gradepro.org, accessed 11 September 2017).
42 Integrated care for older people
studies, specifically in terms of inconsistency,
indirectness, imprecision and publication bias. Except
for one Cochrane review, none of the included
systematic reviews performed GRADE assessments.
Therefore, for each meta-analysis, we conducted an
independent assessment of the quality of results using
GRADE profiler software.
STEP SEVEN
Reporting The final outcome of the systematic reviews, meta-
analysis and the evidence-grading exercise was
summarized in a 2×2 table of all results and
interventions, which was then discussed with the GDG.
43 Annex 4
Hearing loss
Vision impairment
Falls
Caregiver stress
Urinary incontinence
Sub-threshold depression
Cognitive impairment
Undernutrition
Mobility impairment
Fig. 3: Assessment of systematic review quality using the 11 questions of the AMSTAR checklist tool9
11 . “
Wa s t
he co
nfl ict
of in
ter es
t in clu
de d?
”
10 . “
Wa s t
he lik
eli ho
od of
pu bli
ca tio
n b ias
as se
sse d?
”
9. “W
ere th
e m eth
od s u
se d t
o c om
bin e t
he fin
din gs
of st
ud ies
ap pro
pri ate
?”
8. “W
as the
sc ien
tifi c q
ua lity
of th
e i nc
lud ed
st ud
ies us
ed ap
pro pri
ate ly i
n f orm
ula tin
g c on
clu sio
ns? ”
7. “W
as th
e s cie
nti fic
qu ali
ty of
the in
clu de
d s tud
ies as
se sse
d a nd
do cu
me nte
d? ”
6. “W
ere th
e c ha
rac ter
ist ics
of th
e i nc
lud ed
st ud
ies pr
ov ide
d? ”
5. “W
as a
lis t o
f s tud
ies (in
clu de
d a nd
ex clu
de d)
pro vid
ed ?”
4. “W
as th
e s tat
us of
pu bli
ca tio
n ( i.e
. g rey
lit era
tur e)
us ed
as an
in clu
sio n c
rit eri
on ?”
3. “W
as a
co mp
reh en
siv e l
ite rat
ure se
arc h p
erf orm
ed ?”
2. “W
as th
ere du
pli ca
te stu
dy se
lec tio
n a nd
da ta
ex tra
cti on
?”
1. “W
as an
‘a pr
ior i’ d
es ign
pr ov
ide d?
”
Study 10
Cadore et al.
Chou et al.
Daniels et al.
de Vries et al.
Gine-Garriga et al.
Howe et al.
Van Abbema.
Liu C et al.
Burton et al.
Forbes et al.
Pitkala et al.
Milne et al.
Baldwin et al.
Munk et al.
Gillespie et al.
Martin et al.
Kurz et al.
Ekers et al.
Cuijpers et al.
van Zoonen et al.
Wallace et al.
Ostaszkiewicz.
Eustice et al.
Ostaszkiewicz et al.
Dumoulin et al.
Mason et al.
Shaw et al.
Sorensen et al.
Pinquart et al.
Lopez-Hartmann et al.
Smeeth et al.
Barker et al.
Yes No Unclear
Key:
9 Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7(1):10. doi:10.1186/1471-2288-7-10. 10 For full study details, see the ICOPE evidence profiles available at http://www.who.int/ageing/health-systems/icope.
44 Integrated care for older people
Activities of daily living (ADLs): The basic activities necessary for daily life, such as bathing or showering,
dressing, eating, getting in or out of bed or chairs, using
the toilet, and getting around inside the home.
Behavioural activation: A behavioural treatment for depression in which guidance is given to increase the
number of rewarding activities in the person’s life.
Bladder training: A form of behavioural therapy to treat urinary incontinence that aims to increase the
interval between voids. This training is composed of
patient education, scheduled voiding and positive
reinforcement.
Caregiver: A person who provides care and support to someone else. This may include the following:
• helping with self-care, household tasks, mobility, social participation and meaningful activities;
• offering information, advice and emotional support as well as engaging in advocacy, facilitation of
decision-making and peer support, and helping with
advance-care planning;
• offering respite services; and
• engaging in activities to foster intrinsic capacity. Caregivers may include family members, friends,
neighbours, volunteers, care workers and health care
professionals.
Caregiver stress: The cumulative effect of the physical, emotional and economic pressures put on a caregiver.
Case finding: A strategy for targeting resources at individuals or groups who are suspected to be at risk for
a particular disease or adverse health outcomes. It
involves actively, systematically searching for at-risk
people, rather than waiting for them to present with
symptoms or signs of active disease or health conditions.
Care dependence: This arises when functional ability has fallen to a point where an individual is no longer
able without assistance to undertake the basic tasks
necessary for daily living.
Chronic condition: A disease, disorder, injury or trauma that is persistent or has long-lasting effects.
Comprehensive geriatric assessment: A multidimensional assessment of an older person that
includes medical, physical, cognitive, social and spiritual
components; may also include the use of standardized
assessment instruments and/or an interdisciplinary
team to support the process.
Cognitive behavioural therapy (CBT): A type of psychological therapy that involves identifying and
correcting distorted maladaptive beliefs, while using
thought exercises and real experiences to facilitate
symptom reduction and improved functioning.
Cognitive impairment: A loss or abnormality in attention functions, memory functions or higher-level
cognitive functions.
• Attention functions are mental functions that focus on an external stimulus or internal experience for a
specific period of time.
• Memory functions are mental functions that register and store information and retrieve it as
needed.
• Higher-level cognitive functions, often called executive functions, are mental functions that
involve the frontal lobes of the brain. They include
complex goal-directed behaviours such as decision-
making, abstract thinking, making and carrying out
plans, mental flexibility and deciding which
behaviours are appropriate under specific
circumstances.
Cognitive rehabilitation: A method to maximize memory and cognitive functioning despite neurological
difficulties. Cognitive rehabilitation focuses on
identifying and addressing individual needs and goals,
Glossary
45 Glossary
which may require strategies for taking in new
information, or compensatory methods such as using
memory aids.
Cognitive stimulation: Participation in a range of activities designed to improve cognitive and social
functioning.
Cognitive training: Guided practice of specific standardized tasks designed to enhance particular
cognitive functions.
Community health worker: Individuals who provide health education, referral and follow up, case
management, and basic preventive health care and home-
visiting services to specific communities. They provide
support and assistance to individuals and families in
navigating the health and social services system.
Depressive symptoms: The presence of distress or some degree of impaired functioning in the absence of
depressive episode/disorder.
Dietary advice: Recommendations for a healthy diet to help protect against malnutrition and undernutrition as
well as noncommunicable diseases.
Falls: Inadvertently landing on the ground, floor or other lower level.
Functional ability: The combination and interaction of intrinsic capacity with the environment a person
inhabits.
Geriatric syndromes: Complex health states that tend to occur only later in life and that do not fall into discrete
disease categories; often the consequence of multiple
underlying factors, and dysfunction in multiple organ
systems.
Habit retraining: A form of toileting assistance given by a caregiver to adults with urinary incontinence. This
method involves identification of an incontinent person’s
natural voiding pattern and the development of an
individualized toileting schedule, which pre-empts
involuntary bladder emptying.
Healthy Ageing: The process of developing and maintaining the intrinsic capacity and functional ability
that enables well-being in older age.
Hearing loss: Loss or abnormality in sensory functions relating to perception of the presence of sounds or
discriminating the location, pitch, loudness or quality of
sounds.
Intrinsic capacity: The combination of the individual’s physical and mental, including psychological, capacities.
Malnutrition: Deficiencies, excesses or imbalances in a person’s intake of energy and/or nutrients. The term
malnutrition covers two broad groups of conditions. One
is “undernutrition” – which includes stunting (low height
for age), wasting (low weight for height), underweight
(low weight for age) and micronutrient deficiencies or
insufficiencies (a lack of important vitamins and minerals);
the other is overweight, obesity and diet-related
noncommunicable diseases (such as heart disease, stroke,
diabetes and cancer).
Mealtime enhancement strategy: Interventions to improve the mealtime routine, experience or
environment by providing assistance (directly or
indirectly): encouragement with eating, a more
stimulating environment to eat in, increased access to
food, more choice of food or more appealing food
(visually, sensorially).
Mild cognitive impairment: A disorder characterized by memory impairment, learning difficulties and reduced
ability to concentrate on a task for more than brief
periods. There is often a marked feeling of mental
fatigue when mental tasks are attempted, and new
learning is found to be subjectively difficult even when
objectively successful. None of these symptoms is so
severe that a diagnosis of either dementia or delirium
can be made.
Mobility loss: A loss or abnormality in any form of moving by changing body position or location or by
transferring from one place to another, by carrying,
moving or manipulating objects, by walking, running or
climbing, or by using various forms of transportation.
Multimorbidity: The co-occurrence of two or more chronic medical conditions in one person.
Multimodal exercise training: Exercise interventions composed of multiple modalities such as strength
training, aerobic training, balance training or flexibility
exercises.
Multifactorial assessment: A comprehensive assessment to define all possible factors that may be
causing a specific symptom or condition.
Multifactorial intervention: An intervention to address multiple contributing factors; an approach may
include modification plus education, or action to
minimize risk factors.
46 Integrated care for older people
Non-specialist health care providers: General physicians, family physicians, nurses and other clinical
officers working in a health centre or as part of a clinical
team, commonly within a primary health care setting.
Older person: A person whose age has passed the median life expectancy at birth.
Person-centred services: An approach to care that consciously adopts the perspectives of individuals,
families and communities, and sees them as participants
in, as well as beneficiaries of, health care and long-term
care systems that respond to their needs and preferences
in humane and holistic ways. To ensure that person-
centred care is delivered requires that people have the
education and support they need to make decisions and
to participate in their own care. Person-centred care is
organized around the health needs and expectations of
people rather than diseases.
Pelvic floor muscle training (PFMT): Exercises that involve contraction and relaxation of the pelvic muscles,
aiming to strengthen the muscles and enable increased
urethral-closing pressure.
Primary care professionals: Members of a primary care team, a group of professionals with complementary
contributions, mutual respect and shared responsibility
in patient care. Primary care teams are patient-centred,
so their composition and organizational model can
change over time.
Progressive resistance training: A type of exercise in which participants exercise their muscles against a force
or some type of resistance that is progressively increased
as strength improves.
Problem-solving therapy: A type of psychological therapy in which the person systematically identifies
their problems, generates alternative solutions for each
problem, selects the best solution, develops and
conducts a plan, and evaluates whether this has solved
the problem.
Psychological therapies: Interpersonal, individualized treatments to help with a psychiatric or psychological
disorder, problem or adverse circumstance. Treatments
may include cognitive behavioural therapy, problem-
solving therapies, interpersonal therapy or integrative
therapeutic techniques.
Physical activity: Any bodily movement produced by skeletal muscles that requires energy expenditure –
including activities undertaken while working, playing,
carrying out household chores, travelling or engaging in
recreational pursuits.
Physical exercise: Subcategory of physical activity that is planned, structured, repetitive and aims to improve or
maintain one or more components of physical fitness.
Primary health care: A concept based on the principles of equity, participation, intersectoral action, appropriate
technology and a central role played by the health
system. Patients usually have direct access without the
need for referral.
Prompted voiding: A non-pharmacological, behavioural-therapy approach to urinary incontinence
using verbal prompts and positive reinforcement, for
people with or without dementia.
Respite care: Time off from caregiving responsibilities so that caregivers can restore and maintain their own
physical and mental health.
Undernutrition: A global problem that is usually caused by a lack of food, or a limited range of foods with
inadequate amounts of specific nutrients or other food
components, for example protein, dietary fibre and
micronutrients.
Urinary incontinence: Involuntary leakage of urine. The majority of causes can be divided into three types:
• urge incontinence: involuntary leakage of urine associated with, or immediately following, a sudden
compelling need to void;
• stress incontinence: involuntary leakage when performing physical activity, coughing or sneezing;
and
• mixed urinary incontinence: a combination of urge incontinence and stress incontinence.
Visual impairment: A loss or abnormality in sensory functions relating to the perception of the presence of
light, or to sensing the form, size, shape or colour of the
visual stimuli.
World Health Organization
Department of Ageing and Life Course
Avenue Appia 20
1211 Geneva 27
Switzerland
Email: ageing@who.int
Website: www.who.int/ageing
ISBN 978-92-4-155010-9